program_id,submitter_donor_id,submitter_treatment_id,immunotherapy_type,drug_name,drug_reference_identifier,drug_reference_database,immunotherapy_drug_dose_units,prescribed_cumulative_drug_dose,actual_cumulative_drug_dose
SYNTHETIC-1,DONOR_1,TREATMENT_321,Cell-based,Ipilimumab,,RxNorm,cells/kg,146.0,111.0
SYNTHETIC-1,DONOR_2,TREATMENT_322,Other immunomodulatory substances,Alunbrig,239766,NCI Thesaurus,IU/kg,192.0,99.0
SYNTHETIC-1,DONOR_3,TREATMENT_323,Cell-based,Inotuzumab ozogamicin,278936,RxNorm,,93.0,
SYNTHETIC-1,DONOR_4,TREATMENT_324,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,,,54.0,73.0
SYNTHETIC-1,DONOR_5,TREATMENT_325,,Ipilimumab,239766,NCI Thesaurus,cells/kg,134.0,128.0
SYNTHETIC-1,DONOR_6,TREATMENT_326,Immune checkpoint inhibitors,Keytruda,987654,RxNorm,g/m2,128.0,167.0
SYNTHETIC-1,DONOR_7,TREATMENT_327,Other immunomodulatory substances,Durvalumab,8836851,,IU/kg,172.0,57.0
SYNTHETIC-1,DONOR_8,TREATMENT_328,,Pexidartinib,278936,PubChem,mg/m2,180.0,143.0
SYNTHETIC-1,DONOR_9,TREATMENT_329,Cell-based,Tisagenlecleucel,278936,RxNorm,,78.0,167.0
SYNTHETIC-1,DONOR_10,TREATMENT_330,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,,NCI Thesaurus,mg/m2,93.0,184.0
SYNTHETIC-1,DONOR_11,TREATMENT_331,Immune checkpoint inhibitors,Kadcyla,278936,NCI Thesaurus,ug/m2,,
SYNTHETIC-1,DONOR_12,TREATMENT_332,Immune checkpoint inhibitors,Ipilimumab,278936,RxNorm,mg/kg,102.0,60.0
SYNTHETIC-1,DONOR_13,TREATMENT_333,Immune checkpoint inhibitors,Alectinib,,PubChem,mg/m2,181.0,71.0
SYNTHETIC-1,DONOR_14,TREATMENT_334,,Yervoy,,PubChem,mg/kg,107.0,126.0
SYNTHETIC-1,DONOR_15,TREATMENT_335,,,8836851,NCI Thesaurus,,111.0,62.0
SYNTHETIC-1,DONOR_16,TREATMENT_336,,Cobimetinib,4459876,PubChem,IU/m2,153.0,104.0
SYNTHETIC-1,DONOR_17,TREATMENT_337,Other immunomodulatory substances,Pembrolizumab,,NCI Thesaurus,,92.0,100.0
SYNTHETIC-1,DONOR_18,TREATMENT_338,,Venetoclax,239766,NCI Thesaurus,mg/m2,,179.0
SYNTHETIC-1,DONOR_19,TREATMENT_339,Other immunomodulatory substances,Nivolumab,8836851,NCI Thesaurus,IU/m2,78.0,188.0
SYNTHETIC-1,DONOR_20,TREATMENT_340,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,PubChem,mg/m2,55.0,
SYNTHETIC-1,DONOR_21,TREATMENT_341,Immune checkpoint inhibitors,Imfinzi,987654,RxNorm,IU/m2,134.0,137.0
SYNTHETIC-1,DONOR_22,TREATMENT_342,Other immunomodulatory substances,Mekinist,,NCI Thesaurus,IU/kg,122.0,130.0
SYNTHETIC-1,DONOR_23,TREATMENT_343,Monoclonal antibodies other than immune checkpoint inhibitors,Herceptin,8756456,NCI Thesaurus,cells/kg,,
SYNTHETIC-1,DONOR_24,TREATMENT_344,,Osimertinib,278936,RxNorm,ug/m2,108.0,111.0
SYNTHETIC-1,DONOR_25,TREATMENT_345,,Yervoy,239766,,g/m2,142.0,57.0
SYNTHETIC-1,DONOR_26,TREATMENT_346,Cell-based,Afatinib,,,g/m2,144.0,162.0
SYNTHETIC-1,DONOR_27,TREATMENT_347,Monoclonal antibodies other than immune checkpoint inhibitors,Erlotinib,239766,NCI Thesaurus,IU/m2,104.0,
SYNTHETIC-1,DONOR_28,TREATMENT_348,,Dabrafenib,8836851,RxNorm,IU/m2,124.0,149.0
SYNTHETIC-1,DONOR_29,TREATMENT_349,Other immunomodulatory substances,Necitumumab,8756456,NCI Thesaurus,g/m2,73.0,126.0
SYNTHETIC-1,DONOR_30,TREATMENT_350,Cell-based,Iressa,987654,PubChem,,171.0,63.0
SYNTHETIC-1,DONOR_31,TREATMENT_351,Immune checkpoint inhibitors,Yervoy,239766,PubChem,g/m2,126.0,128.0
SYNTHETIC-1,DONOR_32,TREATMENT_352,Immune checkpoint inhibitors,Enhertu,987654,PubChem,IU/kg,76.0,84.0
SYNTHETIC-1,DONOR_33,TREATMENT_353,Immune checkpoint inhibitors,Lynparza,278936,PubChem,mg/m2,115.0,176.0
SYNTHETIC-1,DONOR_34,TREATMENT_354,Cell-based,Belantamab,,,mg/kg,189.0,200.0
SYNTHETIC-1,DONOR_35,TREATMENT_355,Immune checkpoint inhibitors,Axicabtagene ciloleucel,8756456,PubChem,ug/m2,168.0,94.0
SYNTHETIC-1,DONOR_36,TREATMENT_356,,Atezolizumab,,RxNorm,cells/kg,196.0,80.0
SYNTHETIC-1,DONOR_37,TREATMENT_357,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,,IU/m2,155.0,
SYNTHETIC-1,DONOR_38,TREATMENT_358,,Blincyto,4459876,PubChem,mg/kg,142.0,117.0
SYNTHETIC-1,DONOR_39,TREATMENT_359,Cell-based,,4459876,,IU/kg,111.0,162.0
SYNTHETIC-1,DONOR_40,TREATMENT_360,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,239766,RxNorm,mg/m2,,
SYNTHETIC-1,DONOR_1,TREATMENT_361,Immune checkpoint inhibitors,,8836851,RxNorm,,102.0,161.0
SYNTHETIC-1,DONOR_2,TREATMENT_362,Immune checkpoint inhibitors,Brentuximab vedotin,8836851,PubChem,ug/m2,142.0,60.0
SYNTHETIC-1,DONOR_3,TREATMENT_363,,Palbociclib,,PubChem,g/m2,69.0,148.0
SYNTHETIC-1,DONOR_4,TREATMENT_364,Other immunomodulatory substances,Palbociclib,239766,,ug/m2,139.0,64.0
SYNTHETIC-1,DONOR_5,TREATMENT_365,Immune checkpoint inhibitors,Crizotinib,8836851,NCI Thesaurus,mg/m2,191.0,56.0
SYNTHETIC-1,DONOR_6,TREATMENT_366,Immune checkpoint inhibitors,Inotuzumab ozogamicin,987654,PubChem,,,118.0
SYNTHETIC-1,DONOR_7,TREATMENT_367,Cell-based,Pertuzumab,239766,NCI Thesaurus,,53.0,59.0
SYNTHETIC-1,DONOR_8,TREATMENT_368,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,239766,RxNorm,IU/kg,149.0,96.0
SYNTHETIC-1,DONOR_9,TREATMENT_369,,Trastuzumab,8836851,RxNorm,mg/m2,175.0,
SYNTHETIC-1,DONOR_10,TREATMENT_370,,Tecentriq,,RxNorm,IU/m2,57.0,167.0
SYNTHETIC-1,DONOR_11,TREATMENT_371,Other immunomodulatory substances,Keytruda,8836851,RxNorm,cells/kg,,136.0
SYNTHETIC-1,DONOR_12,TREATMENT_372,Immune checkpoint inhibitors,Yervoy,987654,PubChem,IU/m2,126.0,163.0
SYNTHETIC-1,DONOR_13,TREATMENT_373,Immune checkpoint inhibitors,Rituximab,4459876,NCI Thesaurus,g/m2,191.0,
SYNTHETIC-1,DONOR_14,TREATMENT_374,Other immunomodulatory substances,Cotellic,8756456,,,124.0,97.0
SYNTHETIC-1,DONOR_15,TREATMENT_375,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8756456,RxNorm,ug/m2,73.0,88.0
SYNTHETIC-1,DONOR_16,TREATMENT_376,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,987654,RxNorm,IU/kg,137.0,88.0
SYNTHETIC-1,DONOR_17,TREATMENT_377,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,4459876,PubChem,,52.0,181.0
SYNTHETIC-1,DONOR_18,TREATMENT_378,Other immunomodulatory substances,Necitumumab,239766,PubChem,ug/m2,200.0,139.0
SYNTHETIC-1,DONOR_19,TREATMENT_379,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,,RxNorm,,177.0,55.0
SYNTHETIC-1,DONOR_20,TREATMENT_380,Monoclonal antibodies other than immune checkpoint inhibitors,Adcetris,278936,NCI Thesaurus,,159.0,99.0
SYNTHETIC-1,DONOR_21,TREATMENT_381,Monoclonal antibodies other than immune checkpoint inhibitors,Kadcyla,278936,NCI Thesaurus,cells/kg,,98.0
SYNTHETIC-1,DONOR_22,TREATMENT_382,Other immunomodulatory substances,Yervoy,8756456,NCI Thesaurus,IU/m2,166.0,195.0
SYNTHETIC-1,DONOR_23,TREATMENT_383,Other immunomodulatory substances,Tecentriq,239766,PubChem,IU/m2,146.0,
SYNTHETIC-1,DONOR_24,TREATMENT_384,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,,,g/m2,108.0,87.0
SYNTHETIC-1,DONOR_25,TREATMENT_385,Cell-based,Xalkori,8836851,NCI Thesaurus,,90.0,50.0
SYNTHETIC-1,DONOR_26,TREATMENT_386,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,mg/m2,131.0,
SYNTHETIC-1,DONOR_27,TREATMENT_387,Other immunomodulatory substances,Trastuzumab,8836851,PubChem,cells/kg,132.0,103.0
SYNTHETIC-1,DONOR_28,TREATMENT_388,,Tisagenlecleucel,4459876,NCI Thesaurus,,51.0,131.0
SYNTHETIC-1,DONOR_29,TREATMENT_389,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,987654,RxNorm,,,
SYNTHETIC-1,DONOR_30,TREATMENT_390,Cell-based,Lenvatinib,278936,RxNorm,IU/m2,128.0,84.0
SYNTHETIC-1,DONOR_31,TREATMENT_391,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,IU/m2,66.0,71.0
SYNTHETIC-1,DONOR_32,TREATMENT_392,Monoclonal antibodies other than immune checkpoint inhibitors,Ibrance,,NCI Thesaurus,cells/kg,152.0,188.0
SYNTHETIC-1,DONOR_33,TREATMENT_393,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,239766,PubChem,mg/m2,200.0,115.0
SYNTHETIC-1,DONOR_34,TREATMENT_394,Cell-based,Lenvatinib,239766,RxNorm,IU/m2,118.0,125.0
SYNTHETIC-1,DONOR_35,TREATMENT_395,Cell-based,Durvalumab,8756456,NCI Thesaurus,g/m2,,175.0
SYNTHETIC-1,DONOR_36,TREATMENT_396,Immune checkpoint inhibitors,Mekinist,987654,NCI Thesaurus,IU/kg,84.0,
SYNTHETIC-1,DONOR_37,TREATMENT_397,Immune checkpoint inhibitors,Gilteritinib,278936,PubChem,mg/kg,192.0,134.0
SYNTHETIC-1,DONOR_38,TREATMENT_398,Other immunomodulatory substances,Tecentriq,239766,NCI Thesaurus,mg/kg,138.0,115.0
SYNTHETIC-1,DONOR_39,TREATMENT_399,Immune checkpoint inhibitors,Vandetanib,8756456,,g/m2,189.0,117.0
SYNTHETIC-1,DONOR_40,TREATMENT_400,Immune checkpoint inhibitors,Braftovi,987654,RxNorm,g/m2,185.0,190.0
SYNTHETIC-1,DONOR_1,TREATMENT_321,Immune checkpoint inhibitors,Pembrolizumab,4459876,RxNorm,cells/kg,176.0,72.0
SYNTHETIC-1,DONOR_2,TREATMENT_322,Immune checkpoint inhibitors,Yervoy,987654,NCI Thesaurus,IU/kg,99.0,
SYNTHETIC-1,DONOR_3,TREATMENT_323,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,,cells/kg,51.0,93.0
SYNTHETIC-1,DONOR_4,TREATMENT_324,Cell-based,Pembrolizumab,8756456,PubChem,g/m2,101.0,96.0
SYNTHETIC-1,DONOR_5,TREATMENT_325,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,8756456,,mg/m2,62.0,184.0
SYNTHETIC-1,DONOR_6,TREATMENT_326,Cell-based,Rucaparib,,PubChem,ug/m2,148.0,142.0
SYNTHETIC-1,DONOR_7,TREATMENT_327,Cell-based,Pertuzumab,,NCI Thesaurus,IU/m2,92.0,128.0
SYNTHETIC-1,DONOR_8,TREATMENT_328,Other immunomodulatory substances,Cometriq,4459876,PubChem,,,61.0
SYNTHETIC-1,DONOR_9,TREATMENT_329,Other immunomodulatory substances,Afatinib,8836851,PubChem,,,171.0
SYNTHETIC-1,DONOR_10,TREATMENT_330,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,8836851,RxNorm,g/m2,,173.0
SYNTHETIC-1,DONOR_11,TREATMENT_331,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,,NCI Thesaurus,IU/kg,,102.0
SYNTHETIC-1,DONOR_12,TREATMENT_332,Cell-based,,8836851,PubChem,IU/m2,,79.0
SYNTHETIC-1,DONOR_13,TREATMENT_333,Other immunomodulatory substances,Inotuzumab ozogamicin,8836851,NCI Thesaurus,g/m2,195.0,
SYNTHETIC-1,DONOR_14,TREATMENT_334,Other immunomodulatory substances,Yervoy,278936,RxNorm,g/m2,53.0,109.0
SYNTHETIC-1,DONOR_15,TREATMENT_335,Immune checkpoint inhibitors,Tisagenlecleucel,8756456,NCI Thesaurus,,182.0,194.0
SYNTHETIC-1,DONOR_16,TREATMENT_336,Other immunomodulatory substances,Necitumumab,4459876,PubChem,cells/kg,164.0,138.0
SYNTHETIC-1,DONOR_17,TREATMENT_337,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,987654,NCI Thesaurus,IU/m2,116.0,53.0
SYNTHETIC-1,DONOR_18,TREATMENT_338,Cell-based,Abemaciclib,987654,NCI Thesaurus,,120.0,125.0
SYNTHETIC-1,DONOR_19,TREATMENT_339,Other immunomodulatory substances,,8756456,,cells/kg,130.0,
SYNTHETIC-1,DONOR_20,TREATMENT_340,Immune checkpoint inhibitors,Cotellic,8756456,PubChem,cells/kg,186.0,143.0
SYNTHETIC-1,DONOR_21,TREATMENT_341,Monoclonal antibodies other than immune checkpoint inhibitors,,278936,,,153.0,92.0
SYNTHETIC-1,DONOR_22,TREATMENT_342,Other immunomodulatory substances,Yervoy,,RxNorm,g/m2,64.0,142.0
SYNTHETIC-1,DONOR_23,TREATMENT_343,Immune checkpoint inhibitors,Nivolumab,,NCI Thesaurus,cells/kg,114.0,165.0
SYNTHETIC-1,DONOR_24,TREATMENT_344,Cell-based,,8756456,NCI Thesaurus,ug/m2,85.0,187.0
SYNTHETIC-1,DONOR_25,TREATMENT_345,Immune checkpoint inhibitors,Atezolizumab,278936,NCI Thesaurus,IU/kg,118.0,93.0
SYNTHETIC-1,DONOR_26,TREATMENT_346,Immune checkpoint inhibitors,Rituxan,,NCI Thesaurus,ug/m2,185.0,
SYNTHETIC-1,DONOR_27,TREATMENT_347,Immune checkpoint inhibitors,Durvalumab,987654,,mg/kg,57.0,104.0
SYNTHETIC-1,DONOR_28,TREATMENT_348,Other immunomodulatory substances,Niraparib,,PubChem,IU/m2,,
SYNTHETIC-1,DONOR_29,TREATMENT_349,Cell-based,,,NCI Thesaurus,ug/m2,56.0,103.0
SYNTHETIC-1,DONOR_30,TREATMENT_350,Immune checkpoint inhibitors,Cometriq,987654,NCI Thesaurus,ug/m2,136.0,109.0
SYNTHETIC-1,DONOR_31,TREATMENT_351,Immune checkpoint inhibitors,Opdivo,,RxNorm,IU/m2,129.0,116.0
SYNTHETIC-1,DONOR_32,TREATMENT_352,Immune checkpoint inhibitors,Durvalumab,278936,RxNorm,IU/kg,165.0,182.0
SYNTHETIC-1,DONOR_33,TREATMENT_353,Immune checkpoint inhibitors,Alectinib,278936,NCI Thesaurus,g/m2,156.0,101.0
SYNTHETIC-1,DONOR_34,TREATMENT_354,Immune checkpoint inhibitors,Ado-trastuzumab emtansine,8756456,PubChem,IU/kg,170.0,
SYNTHETIC-1,DONOR_35,TREATMENT_355,Immune checkpoint inhibitors,Lenvima,8756456,RxNorm,IU/m2,118.0,
SYNTHETIC-1,DONOR_36,TREATMENT_356,Other immunomodulatory substances,Opdivo,239766,RxNorm,IU/m2,85.0,62.0
SYNTHETIC-1,DONOR_37,TREATMENT_357,Cell-based,Braftovi,987654,NCI Thesaurus,IU/kg,66.0,99.0
SYNTHETIC-1,DONOR_38,TREATMENT_358,Other immunomodulatory substances,Xalkori,987654,NCI Thesaurus,g/m2,,155.0
SYNTHETIC-1,DONOR_39,TREATMENT_359,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,239766,PubChem,,107.0,69.0
SYNTHETIC-1,DONOR_40,TREATMENT_360,Other immunomodulatory substances,Enhertu,4459876,RxNorm,,134.0,156.0
SYNTHETIC-1,DONOR_1,TREATMENT_361,Cell-based,Tafinlar,,PubChem,mg/kg,170.0,120.0
SYNTHETIC-1,DONOR_2,TREATMENT_362,,Selumitinib,,RxNorm,cells/kg,179.0,
SYNTHETIC-1,DONOR_3,TREATMENT_363,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,8836851,PubChem,g/m2,120.0,150.0
SYNTHETIC-1,DONOR_4,TREATMENT_364,Other immunomodulatory substances,Sorafenib,987654,PubChem,,163.0,
SYNTHETIC-1,DONOR_5,TREATMENT_365,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,IU/m2,88.0,114.0
SYNTHETIC-1,DONOR_6,TREATMENT_366,Immune checkpoint inhibitors,Atezolizumab,,,g/m2,67.0,55.0
SYNTHETIC-1,DONOR_7,TREATMENT_367,Other immunomodulatory substances,Ibrance,987654,NCI Thesaurus,g/m2,150.0,136.0
SYNTHETIC-1,DONOR_8,TREATMENT_368,Immune checkpoint inhibitors,Venetoclax,987654,RxNorm,cells/kg,66.0,178.0
SYNTHETIC-1,DONOR_9,TREATMENT_369,Immune checkpoint inhibitors,Pembrolizumab,4459876,,mg/m2,,117.0
SYNTHETIC-1,DONOR_10,TREATMENT_370,Cell-based,Ipilimumab,,NCI Thesaurus,ug/m2,67.0,143.0
SYNTHETIC-1,DONOR_11,TREATMENT_371,Other immunomodulatory substances,,4459876,NCI Thesaurus,mg/m2,,
SYNTHETIC-1,DONOR_12,TREATMENT_372,Cell-based,Atezolizumab,4459876,PubChem,IU/kg,199.0,105.0
SYNTHETIC-1,DONOR_13,TREATMENT_373,Other immunomodulatory substances,Blinatumomab,278936,PubChem,,103.0,191.0
SYNTHETIC-1,DONOR_14,TREATMENT_374,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,239766,NCI Thesaurus,mg/kg,72.0,
SYNTHETIC-1,DONOR_15,TREATMENT_375,,Osimertinib,8836851,NCI Thesaurus,,,106.0
SYNTHETIC-1,DONOR_16,TREATMENT_376,,,239766,RxNorm,mg/kg,92.0,187.0
SYNTHETIC-1,DONOR_17,TREATMENT_377,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,NCI Thesaurus,IU/kg,84.0,128.0
SYNTHETIC-1,DONOR_18,TREATMENT_378,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8756456,,IU/kg,199.0,
SYNTHETIC-1,DONOR_19,TREATMENT_379,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,278936,PubChem,,181.0,67.0
SYNTHETIC-1,DONOR_20,TREATMENT_380,Cell-based,,,RxNorm,cells/kg,127.0,72.0
SYNTHETIC-1,DONOR_21,TREATMENT_381,Immune checkpoint inhibitors,Gefitinib,4459876,PubChem,IU/kg,,156.0
SYNTHETIC-1,DONOR_22,TREATMENT_382,Monoclonal antibodies other than immune checkpoint inhibitors,Belantamab,8836851,RxNorm,ug/m2,58.0,120.0
SYNTHETIC-1,DONOR_23,TREATMENT_383,,Atezolizumab,239766,PubChem,g/m2,172.0,106.0
SYNTHETIC-1,DONOR_24,TREATMENT_384,Cell-based,Ado-trastuzumab emtansine,239766,PubChem,IU/kg,131.0,99.0
SYNTHETIC-1,DONOR_25,TREATMENT_385,Other immunomodulatory substances,Rituxan,278936,,,,141.0
SYNTHETIC-1,DONOR_26,TREATMENT_386,Other immunomodulatory substances,Rituxan,239766,PubChem,mg/kg,167.0,189.0
SYNTHETIC-1,DONOR_27,TREATMENT_387,Immune checkpoint inhibitors,Yescarta,8836851,RxNorm,mg/kg,96.0,
SYNTHETIC-1,DONOR_28,TREATMENT_388,,Cometriq,987654,NCI Thesaurus,mg/m2,173.0,168.0
SYNTHETIC-1,DONOR_29,TREATMENT_389,Other immunomodulatory substances,Imfinzi,8756456,PubChem,mg/kg,192.0,147.0
SYNTHETIC-1,DONOR_30,TREATMENT_390,Monoclonal antibodies other than immune checkpoint inhibitors,,,,g/m2,191.0,83.0
SYNTHETIC-1,DONOR_31,TREATMENT_391,Other immunomodulatory substances,Afatinib,278936,,mg/m2,69.0,
SYNTHETIC-1,DONOR_32,TREATMENT_392,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,8836851,RxNorm,IU/kg,156.0,
SYNTHETIC-1,DONOR_33,TREATMENT_393,Immune checkpoint inhibitors,Tecentriq,,RxNorm,mg/kg,101.0,193.0
SYNTHETIC-1,DONOR_34,TREATMENT_394,Immune checkpoint inhibitors,Atezolizumab,278936,PubChem,mg/m2,113.0,87.0
SYNTHETIC-1,DONOR_35,TREATMENT_395,Cell-based,Blincyto,4459876,RxNorm,cells/kg,160.0,97.0
SYNTHETIC-1,DONOR_36,TREATMENT_396,Cell-based,Nivolumab,8836851,RxNorm,ug/m2,62.0,183.0
SYNTHETIC-1,DONOR_37,TREATMENT_397,Cell-based,Kadcyla,987654,PubChem,mg/m2,,178.0
SYNTHETIC-1,DONOR_38,TREATMENT_398,Immune checkpoint inhibitors,Belantamab,239766,,IU/m2,75.0,
SYNTHETIC-1,DONOR_39,TREATMENT_399,Cell-based,Cotellic,8756456,PubChem,mg/kg,,141.0
SYNTHETIC-1,DONOR_40,TREATMENT_400,Immune checkpoint inhibitors,Ipilimumab,278936,RxNorm,ug/m2,158.0,146.0
SYNTHETIC-1,DONOR_1,TREATMENT_321,Monoclonal antibodies other than immune checkpoint inhibitors,Obinutuzumab,4459876,,mg/kg,166.0,174.0
SYNTHETIC-1,DONOR_2,TREATMENT_322,Other immunomodulatory substances,Zelboraf,8836851,NCI Thesaurus,ug/m2,154.0,157.0
SYNTHETIC-1,DONOR_3,TREATMENT_323,Other immunomodulatory substances,Nivolumab,4459876,,mg/kg,128.0,178.0
SYNTHETIC-1,DONOR_4,TREATMENT_324,Monoclonal antibodies other than immune checkpoint inhibitors,Blincyto,987654,RxNorm,mg/kg,97.0,157.0
SYNTHETIC-1,DONOR_5,TREATMENT_325,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,239766,,cells/kg,156.0,
SYNTHETIC-1,DONOR_6,TREATMENT_326,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,8756456,NCI Thesaurus,mg/kg,181.0,
SYNTHETIC-1,DONOR_7,TREATMENT_327,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,8756456,,,61.0,87.0
SYNTHETIC-1,DONOR_8,TREATMENT_328,Other immunomodulatory substances,Durvalumab,8756456,RxNorm,g/m2,105.0,157.0
SYNTHETIC-1,DONOR_9,TREATMENT_329,Monoclonal antibodies other than immune checkpoint inhibitors,Cometriq,8756456,NCI Thesaurus,cells/kg,186.0,135.0
SYNTHETIC-1,DONOR_10,TREATMENT_330,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,8756456,NCI Thesaurus,mg/kg,,93.0
SYNTHETIC-1,DONOR_11,TREATMENT_331,Monoclonal antibodies other than immune checkpoint inhibitors,Kisqali,,PubChem,g/m2,164.0,
SYNTHETIC-1,DONOR_12,TREATMENT_332,Immune checkpoint inhibitors,,987654,RxNorm,mg/kg,97.0,
SYNTHETIC-1,DONOR_13,TREATMENT_333,Cell-based,Lenvatinib,8756456,RxNorm,,172.0,67.0
SYNTHETIC-1,DONOR_14,TREATMENT_334,Immune checkpoint inhibitors,Durvalumab,4459876,PubChem,g/m2,105.0,151.0
SYNTHETIC-1,DONOR_15,TREATMENT_335,Immune checkpoint inhibitors,Tecentriq,8756456,NCI Thesaurus,IU/kg,157.0,173.0
SYNTHETIC-1,DONOR_16,TREATMENT_336,,Kymriah,239766,NCI Thesaurus,g/m2,75.0,165.0
SYNTHETIC-1,DONOR_17,TREATMENT_337,,Pembrolizumab,8756456,PubChem,,82.0,
SYNTHETIC-1,DONOR_18,TREATMENT_338,Other immunomodulatory substances,Lenvatinib,4459876,NCI Thesaurus,cells/kg,,172.0
SYNTHETIC-1,DONOR_19,TREATMENT_339,Cell-based,Palbociclib,4459876,RxNorm,cells/kg,70.0,56.0
SYNTHETIC-1,DONOR_20,TREATMENT_340,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,RxNorm,mg/m2,190.0,108.0
SYNTHETIC-1,DONOR_21,TREATMENT_341,Monoclonal antibodies other than immune checkpoint inhibitors,Caprelsa,987654,PubChem,IU/m2,,
SYNTHETIC-1,DONOR_22,TREATMENT_342,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,239766,NCI Thesaurus,IU/kg,129.0,191.0
SYNTHETIC-1,DONOR_23,TREATMENT_343,Cell-based,,987654,RxNorm,IU/kg,171.0,174.0
SYNTHETIC-1,DONOR_24,TREATMENT_344,,Venetoclax,8756456,NCI Thesaurus,IU/m2,133.0,173.0
SYNTHETIC-1,DONOR_25,TREATMENT_345,Cell-based,Opdivo,,NCI Thesaurus,IU/m2,74.0,175.0
SYNTHETIC-1,DONOR_26,TREATMENT_346,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,239766,PubChem,mg/m2,135.0,50.0
SYNTHETIC-1,DONOR_27,TREATMENT_347,Other immunomodulatory substances,Zykadia,8756456,RxNorm,mg/kg,,177.0
SYNTHETIC-1,DONOR_28,TREATMENT_348,Cell-based,Keytruda,987654,PubChem,cells/kg,,187.0
SYNTHETIC-1,DONOR_29,TREATMENT_349,,Sorafenib,239766,NCI Thesaurus,cells/kg,190.0,66.0
SYNTHETIC-1,DONOR_30,TREATMENT_350,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,RxNorm,cells/kg,167.0,185.0
SYNTHETIC-1,DONOR_31,TREATMENT_351,Cell-based,Mektovi,987654,NCI Thesaurus,IU/kg,,
SYNTHETIC-1,DONOR_32,TREATMENT_352,Other immunomodulatory substances,,278936,PubChem,,96.0,135.0
SYNTHETIC-1,DONOR_33,TREATMENT_353,,Cometriq,987654,RxNorm,cells/kg,64.0,57.0
SYNTHETIC-1,DONOR_34,TREATMENT_354,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,239766,NCI Thesaurus,ug/m2,195.0,153.0
SYNTHETIC-1,DONOR_35,TREATMENT_355,Cell-based,Vemurafenib,,NCI Thesaurus,ug/m2,62.0,107.0
SYNTHETIC-1,DONOR_36,TREATMENT_356,Cell-based,Keytruda,239766,RxNorm,ug/m2,124.0,192.0
SYNTHETIC-1,DONOR_37,TREATMENT_357,Other immunomodulatory substances,Gefitinib,239766,NCI Thesaurus,IU/kg,75.0,74.0
SYNTHETIC-1,DONOR_38,TREATMENT_358,Immune checkpoint inhibitors,Zejula,4459876,RxNorm,cells/kg,155.0,197.0
SYNTHETIC-1,DONOR_39,TREATMENT_359,Cell-based,Alectinib,,NCI Thesaurus,IU/kg,,104.0
SYNTHETIC-1,DONOR_40,TREATMENT_360,Immune checkpoint inhibitors,Brentuximab vedotin,,NCI Thesaurus,g/m2,132.0,
SYNTHETIC-1,DONOR_1,TREATMENT_361,Cell-based,Brigatinib,278936,PubChem,mg/kg,66.0,137.0
SYNTHETIC-1,DONOR_2,TREATMENT_362,Immune checkpoint inhibitors,Abemaciclib,987654,NCI Thesaurus,,88.0,76.0
SYNTHETIC-1,DONOR_3,TREATMENT_363,Immune checkpoint inhibitors,Copanlisib,239766,RxNorm,cells/kg,115.0,148.0
SYNTHETIC-1,DONOR_4,TREATMENT_364,Immune checkpoint inhibitors,,8756456,PubChem,ug/m2,141.0,101.0
SYNTHETIC-1,DONOR_5,TREATMENT_365,Cell-based,Rubraca,8836851,PubChem,,,
SYNTHETIC-1,DONOR_6,TREATMENT_366,,Rituxan,,RxNorm,IU/m2,123.0,66.0
SYNTHETIC-1,DONOR_7,TREATMENT_367,Immune checkpoint inhibitors,,987654,RxNorm,,143.0,
SYNTHETIC-1,DONOR_8,TREATMENT_368,Cell-based,Venetoclax,4459876,,mg/kg,176.0,73.0
SYNTHETIC-1,DONOR_9,TREATMENT_369,Other immunomodulatory substances,Opdivo,987654,,IU/kg,75.0,
SYNTHETIC-1,DONOR_10,TREATMENT_370,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,4459876,NCI Thesaurus,mg/m2,,147.0
SYNTHETIC-1,DONOR_11,TREATMENT_371,Immune checkpoint inhibitors,,239766,PubChem,g/m2,74.0,137.0
SYNTHETIC-1,DONOR_12,TREATMENT_372,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,278936,,cells/kg,,100.0
SYNTHETIC-1,DONOR_13,TREATMENT_373,Cell-based,Palbociclib,8756456,PubChem,cells/kg,168.0,81.0
SYNTHETIC-1,DONOR_14,TREATMENT_374,Other immunomodulatory substances,Pembrolizumab,4459876,RxNorm,mg/m2,117.0,
SYNTHETIC-1,DONOR_15,TREATMENT_375,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,239766,PubChem,g/m2,126.0,151.0
SYNTHETIC-1,DONOR_16,TREATMENT_376,Other immunomodulatory substances,Perjeta,8836851,RxNorm,,110.0,166.0
SYNTHETIC-1,DONOR_17,TREATMENT_377,Other immunomodulatory substances,Gefitinib,,NCI Thesaurus,IU/m2,100.0,83.0
SYNTHETIC-1,DONOR_18,TREATMENT_378,Immune checkpoint inhibitors,Tecentriq,239766,PubChem,ug/m2,138.0,85.0
SYNTHETIC-1,DONOR_19,TREATMENT_379,Other immunomodulatory substances,Yervoy,239766,PubChem,mg/m2,189.0,
SYNTHETIC-1,DONOR_20,TREATMENT_380,Other immunomodulatory substances,Vandetanib,278936,RxNorm,IU/kg,125.0,97.0
SYNTHETIC-1,DONOR_21,TREATMENT_381,Cell-based,Durvalumab,8756456,NCI Thesaurus,ug/m2,121.0,189.0
SYNTHETIC-1,DONOR_22,TREATMENT_382,Cell-based,Opdivo,278936,PubChem,ug/m2,147.0,156.0
SYNTHETIC-1,DONOR_23,TREATMENT_383,Immune checkpoint inhibitors,Besponsa,278936,RxNorm,IU/m2,106.0,
SYNTHETIC-1,DONOR_24,TREATMENT_384,Cell-based,Herceptin,4459876,PubChem,cells/kg,,
SYNTHETIC-1,DONOR_25,TREATMENT_385,Other immunomodulatory substances,,,PubChem,mg/m2,63.0,158.0
SYNTHETIC-1,DONOR_26,TREATMENT_386,Cell-based,Caprelsa,4459876,RxNorm,IU/kg,,181.0
SYNTHETIC-1,DONOR_27,TREATMENT_387,Immune checkpoint inhibitors,Vandetanib,8836851,PubChem,g/m2,,67.0
SYNTHETIC-1,DONOR_28,TREATMENT_388,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,NCI Thesaurus,mg/m2,90.0,
SYNTHETIC-1,DONOR_29,TREATMENT_389,Other immunomodulatory substances,,8836851,RxNorm,mg/m2,162.0,133.0
SYNTHETIC-1,DONOR_30,TREATMENT_390,Cell-based,Atezolizumab,239766,,mg/kg,138.0,
SYNTHETIC-1,DONOR_31,TREATMENT_391,Immune checkpoint inhibitors,Venclexta,,RxNorm,mg/kg,185.0,181.0
SYNTHETIC-1,DONOR_32,TREATMENT_392,Immune checkpoint inhibitors,Ipilimumab,987654,PubChem,,,
SYNTHETIC-1,DONOR_33,TREATMENT_393,Monoclonal antibodies other than immune checkpoint inhibitors,Osimertinib,8756456,RxNorm,IU/m2,,68.0
SYNTHETIC-1,DONOR_34,TREATMENT_394,Cell-based,,987654,,IU/kg,114.0,
SYNTHETIC-1,DONOR_35,TREATMENT_395,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,8836851,PubChem,ug/m2,180.0,61.0
SYNTHETIC-1,DONOR_36,TREATMENT_396,Cell-based,Adcetris,4459876,NCI Thesaurus,cells/kg,154.0,107.0
SYNTHETIC-1,DONOR_37,TREATMENT_397,,Cometriq,8836851,NCI Thesaurus,IU/m2,158.0,162.0
SYNTHETIC-1,DONOR_38,TREATMENT_398,Monoclonal antibodies other than immune checkpoint inhibitors,Tagrisso,239766,RxNorm,mg/kg,150.0,188.0
SYNTHETIC-1,DONOR_39,TREATMENT_399,Cell-based,Brentuximab vedotin,987654,NCI Thesaurus,IU/m2,156.0,119.0
SYNTHETIC-1,DONOR_40,TREATMENT_400,Immune checkpoint inhibitors,,987654,RxNorm,IU/kg,178.0,84.0
SYNTHETIC-1,DONOR_1,TREATMENT_321,Monoclonal antibodies other than immune checkpoint inhibitors,Yescarta,239766,,mg/m2,197.0,119.0
SYNTHETIC-1,DONOR_2,TREATMENT_322,Cell-based,Zelboraf,987654,NCI Thesaurus,ug/m2,131.0,
SYNTHETIC-1,DONOR_3,TREATMENT_323,Immune checkpoint inhibitors,Gefitinib,8756456,,IU/m2,,134.0
SYNTHETIC-1,DONOR_4,TREATMENT_324,Monoclonal antibodies other than immune checkpoint inhibitors,Vemurafenib,4459876,PubChem,IU/kg,,96.0
SYNTHETIC-1,DONOR_5,TREATMENT_325,,Enhertu,987654,PubChem,cells/kg,167.0,91.0
SYNTHETIC-1,DONOR_6,TREATMENT_326,Cell-based,,8756456,PubChem,mg/kg,93.0,105.0
SYNTHETIC-1,DONOR_7,TREATMENT_327,Other immunomodulatory substances,Belantamab,8756456,NCI Thesaurus,IU/m2,56.0,186.0
SYNTHETIC-1,DONOR_8,TREATMENT_328,Other immunomodulatory substances,Ipilimumab,239766,RxNorm,,145.0,146.0
SYNTHETIC-1,DONOR_9,TREATMENT_329,Cell-based,Caprelsa,278936,,IU/m2,94.0,173.0
SYNTHETIC-1,DONOR_10,TREATMENT_330,Monoclonal antibodies other than immune checkpoint inhibitors,Perjeta,278936,PubChem,mg/m2,79.0,107.0
SYNTHETIC-1,DONOR_11,TREATMENT_331,Cell-based,Darzalex,987654,RxNorm,cells/kg,,
SYNTHETIC-1,DONOR_12,TREATMENT_332,Other immunomodulatory substances,Imfinzi,8756456,PubChem,IU/m2,183.0,80.0
SYNTHETIC-1,DONOR_13,TREATMENT_333,Other immunomodulatory substances,Caprelsa,4459876,NCI Thesaurus,mg/kg,72.0,196.0
SYNTHETIC-1,DONOR_14,TREATMENT_334,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,RxNorm,ug/m2,98.0,135.0
SYNTHETIC-1,DONOR_15,TREATMENT_335,Other immunomodulatory substances,Durvalumab,278936,NCI Thesaurus,,,89.0
SYNTHETIC-1,DONOR_16,TREATMENT_336,,Binimetinib,278936,NCI Thesaurus,IU/kg,110.0,138.0
SYNTHETIC-1,DONOR_17,TREATMENT_337,Cell-based,Pembrolizumab,,PubChem,,192.0,104.0
SYNTHETIC-1,DONOR_18,TREATMENT_338,Cell-based,Pembrolizumab,987654,,g/m2,169.0,199.0
SYNTHETIC-1,DONOR_19,TREATMENT_339,,Ibrance,4459876,,g/m2,194.0,124.0
SYNTHETIC-1,DONOR_20,TREATMENT_340,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,8836851,RxNorm,,,185.0
SYNTHETIC-1,DONOR_21,TREATMENT_341,Other immunomodulatory substances,Atezolizumab,,NCI Thesaurus,mg/m2,83.0,57.0
SYNTHETIC-1,DONOR_22,TREATMENT_342,Cell-based,Zejula,278936,PubChem,,139.0,123.0
SYNTHETIC-1,DONOR_23,TREATMENT_343,Other immunomodulatory substances,Cabozantinib,,NCI Thesaurus,ug/m2,55.0,60.0
SYNTHETIC-1,DONOR_24,TREATMENT_344,Immune checkpoint inhibitors,Zykadia,987654,PubChem,IU/m2,,131.0
SYNTHETIC-1,DONOR_25,TREATMENT_345,Cell-based,Durvalumab,987654,NCI Thesaurus,mg/kg,143.0,
SYNTHETIC-1,DONOR_26,TREATMENT_346,Cell-based,,239766,RxNorm,,54.0,
SYNTHETIC-1,DONOR_27,TREATMENT_347,Cell-based,Nexavar,,RxNorm,IU/m2,,197.0
SYNTHETIC-1,DONOR_28,TREATMENT_348,Cell-based,Nivolumab,8756456,NCI Thesaurus,mg/kg,166.0,142.0
SYNTHETIC-1,DONOR_29,TREATMENT_349,Other immunomodulatory substances,,,,cells/kg,67.0,160.0
SYNTHETIC-1,DONOR_30,TREATMENT_350,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,,PubChem,mg/kg,166.0,162.0
SYNTHETIC-1,DONOR_31,TREATMENT_351,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,,,69.0,144.0
SYNTHETIC-1,DONOR_32,TREATMENT_352,Immune checkpoint inhibitors,,239766,RxNorm,g/m2,,134.0
SYNTHETIC-1,DONOR_33,TREATMENT_353,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,8836851,,IU/m2,72.0,74.0
SYNTHETIC-1,DONOR_34,TREATMENT_354,Cell-based,Atezolizumab,239766,NCI Thesaurus,IU/kg,193.0,91.0
SYNTHETIC-1,DONOR_35,TREATMENT_355,Other immunomodulatory substances,Pexidartinib,4459876,NCI Thesaurus,cells/kg,143.0,56.0
SYNTHETIC-1,DONOR_36,TREATMENT_356,Immune checkpoint inhibitors,,278936,PubChem,,148.0,192.0
SYNTHETIC-1,DONOR_37,TREATMENT_357,Other immunomodulatory substances,Afatinib,4459876,PubChem,,106.0,
SYNTHETIC-1,DONOR_38,TREATMENT_358,Other immunomodulatory substances,Copanlisib,8836851,RxNorm,mg/kg,146.0,150.0
SYNTHETIC-1,DONOR_39,TREATMENT_359,Cell-based,,8756456,NCI Thesaurus,g/m2,89.0,104.0
SYNTHETIC-1,DONOR_40,TREATMENT_360,Immune checkpoint inhibitors,Pembrolizumab,,PubChem,,56.0,190.0
SYNTHETIC-1,DONOR_1,TREATMENT_361,Other immunomodulatory substances,Darzalex,8836851,RxNorm,,,152.0
SYNTHETIC-1,DONOR_2,TREATMENT_362,Immune checkpoint inhibitors,Yervoy,,NCI Thesaurus,g/m2,150.0,124.0
SYNTHETIC-1,DONOR_3,TREATMENT_363,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,987654,RxNorm,mg/kg,138.0,81.0
SYNTHETIC-1,DONOR_4,TREATMENT_364,Immune checkpoint inhibitors,Pembrolizumab,278936,NCI Thesaurus,mg/kg,192.0,137.0
SYNTHETIC-1,DONOR_5,TREATMENT_365,Cell-based,,8756456,PubChem,IU/kg,66.0,161.0
SYNTHETIC-1,DONOR_6,TREATMENT_366,Cell-based,Rucaparib,239766,PubChem,IU/m2,93.0,193.0
SYNTHETIC-1,DONOR_7,TREATMENT_367,Immune checkpoint inhibitors,Venetoclax,,PubChem,mg/kg,191.0,165.0
SYNTHETIC-1,DONOR_8,TREATMENT_368,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,4459876,NCI Thesaurus,,,
SYNTHETIC-1,DONOR_9,TREATMENT_369,Other immunomodulatory substances,Caprelsa,8756456,NCI Thesaurus,ug/m2,188.0,
SYNTHETIC-1,DONOR_10,TREATMENT_370,Immune checkpoint inhibitors,Gazyva,8756456,NCI Thesaurus,ug/m2,78.0,142.0
SYNTHETIC-1,DONOR_11,TREATMENT_371,Cell-based,,4459876,NCI Thesaurus,mg/kg,,70.0
SYNTHETIC-1,DONOR_12,TREATMENT_372,Other immunomodulatory substances,Nexavar,278936,NCI Thesaurus,mg/m2,93.0,170.0
SYNTHETIC-1,DONOR_13,TREATMENT_373,Immune checkpoint inhibitors,Durvalumab,,NCI Thesaurus,mg/kg,115.0,
SYNTHETIC-1,DONOR_14,TREATMENT_374,Cell-based,Besponsa,239766,,IU/kg,161.0,174.0
SYNTHETIC-1,DONOR_15,TREATMENT_375,Other immunomodulatory substances,Venclexta,8836851,NCI Thesaurus,ug/m2,139.0,
SYNTHETIC-1,DONOR_16,TREATMENT_376,Immune checkpoint inhibitors,Cotellic,,NCI Thesaurus,g/m2,143.0,170.0
SYNTHETIC-1,DONOR_17,TREATMENT_377,Monoclonal antibodies other than immune checkpoint inhibitors,,,RxNorm,,126.0,176.0
SYNTHETIC-1,DONOR_18,TREATMENT_378,,Keytruda,8756456,PubChem,g/m2,,101.0
SYNTHETIC-1,DONOR_19,TREATMENT_379,Other immunomodulatory substances,Nexavar,,PubChem,cells/kg,129.0,80.0
SYNTHETIC-1,DONOR_20,TREATMENT_380,Other immunomodulatory substances,Mektovi,278936,NCI Thesaurus,IU/kg,98.0,140.0
SYNTHETIC-1,DONOR_21,TREATMENT_381,Other immunomodulatory substances,Abemaciclib,987654,PubChem,g/m2,,154.0
SYNTHETIC-1,DONOR_22,TREATMENT_382,Cell-based,Selumitinib,239766,PubChem,cells/kg,156.0,
SYNTHETIC-1,DONOR_23,TREATMENT_383,Cell-based,Brentuximab vedotin,987654,RxNorm,IU/m2,63.0,192.0
SYNTHETIC-1,DONOR_24,TREATMENT_384,Immune checkpoint inhibitors,Daratumumab,239766,PubChem,cells/kg,161.0,
SYNTHETIC-1,DONOR_25,TREATMENT_385,Cell-based,Nivolumab,239766,RxNorm,mg/kg,185.0,108.0
SYNTHETIC-1,DONOR_26,TREATMENT_386,Immune checkpoint inhibitors,Keytruda,,PubChem,IU/m2,162.0,145.0
SYNTHETIC-1,DONOR_27,TREATMENT_387,Cell-based,Yervoy,4459876,PubChem,IU/m2,106.0,121.0
SYNTHETIC-1,DONOR_28,TREATMENT_388,Immune checkpoint inhibitors,Nivolumab,4459876,PubChem,ug/m2,59.0,163.0
SYNTHETIC-1,DONOR_29,TREATMENT_389,Other immunomodulatory substances,Imfinzi,8836851,PubChem,,146.0,124.0
SYNTHETIC-1,DONOR_30,TREATMENT_390,,Gilteritinib,987654,NCI Thesaurus,mg/kg,,
SYNTHETIC-1,DONOR_31,TREATMENT_391,Other immunomodulatory substances,Tecentriq,278936,RxNorm,mg/kg,82.0,116.0
SYNTHETIC-1,DONOR_32,TREATMENT_392,Cell-based,,,NCI Thesaurus,IU/kg,142.0,126.0
SYNTHETIC-1,DONOR_33,TREATMENT_393,Other immunomodulatory substances,Zejula,8836851,RxNorm,ug/m2,,193.0
SYNTHETIC-1,DONOR_34,TREATMENT_394,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,NCI Thesaurus,ug/m2,132.0,102.0
SYNTHETIC-1,DONOR_35,TREATMENT_395,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,239766,RxNorm,IU/m2,180.0,
SYNTHETIC-1,DONOR_36,TREATMENT_396,Immune checkpoint inhibitors,Tarceva,8836851,PubChem,IU/kg,167.0,158.0
SYNTHETIC-1,DONOR_37,TREATMENT_397,Immune checkpoint inhibitors,Pembrolizumab,8756456,,ug/m2,,114.0
SYNTHETIC-1,DONOR_38,TREATMENT_398,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,239766,PubChem,IU/kg,,52.0
SYNTHETIC-1,DONOR_39,TREATMENT_399,Other immunomodulatory substances,Selumitinib,987654,PubChem,mg/m2,109.0,141.0
SYNTHETIC-1,DONOR_40,TREATMENT_400,Immune checkpoint inhibitors,Yervoy,4459876,,IU/m2,185.0,200.0
SYNTHETIC-1,DONOR_1,TREATMENT_321,Cell-based,Gilotrif,8836851,RxNorm,IU/m2,91.0,193.0
SYNTHETIC-1,DONOR_2,TREATMENT_322,Other immunomodulatory substances,Niraparib,4459876,RxNorm,,134.0,
SYNTHETIC-1,DONOR_3,TREATMENT_323,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,PubChem,ug/m2,178.0,136.0
SYNTHETIC-1,DONOR_4,TREATMENT_324,Other immunomodulatory substances,Encorafenib,,RxNorm,ug/m2,,118.0
SYNTHETIC-1,DONOR_5,TREATMENT_325,Other immunomodulatory substances,,278936,RxNorm,mg/kg,117.0,52.0
SYNTHETIC-1,DONOR_6,TREATMENT_326,,Afatinib,987654,RxNorm,IU/m2,,197.0
SYNTHETIC-1,DONOR_7,TREATMENT_327,Other immunomodulatory substances,Gilteritinib,8836851,PubChem,,92.0,96.0
SYNTHETIC-1,DONOR_8,TREATMENT_328,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,,IU/m2,,51.0
SYNTHETIC-1,DONOR_9,TREATMENT_329,Other immunomodulatory substances,,8756456,NCI Thesaurus,g/m2,113.0,51.0
SYNTHETIC-1,DONOR_10,TREATMENT_330,Cell-based,Tecentriq,8836851,NCI Thesaurus,g/m2,,101.0
SYNTHETIC-1,DONOR_11,TREATMENT_331,Cell-based,Imfinzi,8756456,,IU/kg,174.0,62.0
SYNTHETIC-1,DONOR_12,TREATMENT_332,Immune checkpoint inhibitors,Gefitinib,278936,PubChem,,172.0,127.0
SYNTHETIC-1,DONOR_13,TREATMENT_333,Immune checkpoint inhibitors,,8836851,PubChem,g/m2,185.0,162.0
SYNTHETIC-1,DONOR_14,TREATMENT_334,Cell-based,Ipilimumab,8756456,RxNorm,g/m2,169.0,117.0
SYNTHETIC-1,DONOR_15,TREATMENT_335,Immune checkpoint inhibitors,,,RxNorm,,112.0,
SYNTHETIC-1,DONOR_16,TREATMENT_336,,Tecentriq,239766,PubChem,,150.0,59.0
SYNTHETIC-1,DONOR_17,TREATMENT_337,Immune checkpoint inhibitors,Tagrisso,4459876,PubChem,IU/m2,198.0,115.0
SYNTHETIC-1,DONOR_18,TREATMENT_338,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,IU/m2,105.0,107.0
SYNTHETIC-1,DONOR_19,TREATMENT_339,Immune checkpoint inhibitors,Osimertinib,8756456,RxNorm,mg/kg,149.0,196.0
SYNTHETIC-1,DONOR_20,TREATMENT_340,,Ipilimumab,278936,NCI Thesaurus,IU/kg,125.0,147.0
SYNTHETIC-1,DONOR_21,TREATMENT_341,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,987654,NCI Thesaurus,,87.0,192.0
SYNTHETIC-1,DONOR_22,TREATMENT_342,Cell-based,Atezolizumab,4459876,PubChem,IU/kg,79.0,
SYNTHETIC-1,DONOR_23,TREATMENT_343,Monoclonal antibodies other than immune checkpoint inhibitors,Gefitinib,239766,PubChem,mg/kg,183.0,95.0
SYNTHETIC-1,DONOR_24,TREATMENT_344,Cell-based,Xalkori,,NCI Thesaurus,IU/kg,59.0,150.0
SYNTHETIC-1,DONOR_25,TREATMENT_345,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,8756456,PubChem,IU/kg,61.0,200.0
SYNTHETIC-1,DONOR_26,TREATMENT_346,Immune checkpoint inhibitors,Nivolumab,,RxNorm,cells/kg,,114.0
SYNTHETIC-1,DONOR_27,TREATMENT_347,,Gilotrif,987654,,g/m2,56.0,118.0
SYNTHETIC-1,DONOR_28,TREATMENT_348,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,239766,NCI Thesaurus,g/m2,133.0,96.0
SYNTHETIC-1,DONOR_29,TREATMENT_349,Other immunomodulatory substances,Caprelsa,8756456,RxNorm,,63.0,71.0
SYNTHETIC-1,DONOR_30,TREATMENT_350,,Tecentriq,239766,PubChem,g/m2,97.0,86.0
SYNTHETIC-1,DONOR_31,TREATMENT_351,Cell-based,Ibrance,4459876,PubChem,IU/m2,127.0,153.0
SYNTHETIC-1,DONOR_32,TREATMENT_352,Monoclonal antibodies other than immune checkpoint inhibitors,Zejula,8836851,RxNorm,IU/kg,110.0,183.0
SYNTHETIC-1,DONOR_33,TREATMENT_353,Immune checkpoint inhibitors,Keytruda,,PubChem,IU/kg,174.0,57.0
SYNTHETIC-1,DONOR_34,TREATMENT_354,Cell-based,,987654,PubChem,IU/m2,146.0,101.0
SYNTHETIC-1,DONOR_35,TREATMENT_355,Immune checkpoint inhibitors,Binimetinib,987654,RxNorm,,99.0,
SYNTHETIC-1,DONOR_36,TREATMENT_356,Immune checkpoint inhibitors,Yervoy,,,IU/m2,127.0,180.0
SYNTHETIC-1,DONOR_37,TREATMENT_357,Immune checkpoint inhibitors,Kymriah,4459876,NCI Thesaurus,ug/m2,166.0,70.0
SYNTHETIC-1,DONOR_38,TREATMENT_358,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,8756456,RxNorm,cells/kg,199.0,116.0
SYNTHETIC-1,DONOR_39,TREATMENT_359,Other immunomodulatory substances,Besponsa,4459876,PubChem,ug/m2,158.0,89.0
SYNTHETIC-1,DONOR_40,TREATMENT_360,Cell-based,Ribociclib,987654,NCI Thesaurus,ug/m2,,62.0
SYNTHETIC-1,DONOR_1,TREATMENT_361,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,4459876,RxNorm,,149.0,59.0
SYNTHETIC-1,DONOR_2,TREATMENT_362,Immune checkpoint inhibitors,Darzalex,987654,PubChem,cells/kg,189.0,197.0
SYNTHETIC-1,DONOR_3,TREATMENT_363,Other immunomodulatory substances,,8756456,NCI Thesaurus,mg/m2,187.0,77.0
SYNTHETIC-1,DONOR_4,TREATMENT_364,Immune checkpoint inhibitors,Lenvatinib,278936,,cells/kg,182.0,
SYNTHETIC-1,DONOR_5,TREATMENT_365,Immune checkpoint inhibitors,Keytruda,278936,NCI Thesaurus,cells/kg,169.0,196.0
SYNTHETIC-1,DONOR_6,TREATMENT_366,Cell-based,Gilteritinib,8836851,NCI Thesaurus,mg/m2,145.0,60.0
SYNTHETIC-1,DONOR_7,TREATMENT_367,Other immunomodulatory substances,Venclexta,239766,,ug/m2,,145.0
SYNTHETIC-1,DONOR_8,TREATMENT_368,Immune checkpoint inhibitors,Durvalumab,,NCI Thesaurus,mg/kg,97.0,81.0
SYNTHETIC-1,DONOR_9,TREATMENT_369,Cell-based,Tecentriq,8836851,PubChem,IU/m2,100.0,
SYNTHETIC-1,DONOR_10,TREATMENT_370,Cell-based,Nivolumab,8836851,PubChem,,69.0,88.0
SYNTHETIC-1,DONOR_11,TREATMENT_371,Immune checkpoint inhibitors,Binimetinib,4459876,,cells/kg,,191.0
SYNTHETIC-1,DONOR_12,TREATMENT_372,Other immunomodulatory substances,Pertuzumab,987654,RxNorm,mg/kg,107.0,176.0
SYNTHETIC-1,DONOR_13,TREATMENT_373,Other immunomodulatory substances,,,RxNorm,cells/kg,75.0,
SYNTHETIC-1,DONOR_14,TREATMENT_374,Other immunomodulatory substances,Alectinib,8836851,NCI Thesaurus,IU/m2,,74.0
SYNTHETIC-1,DONOR_15,TREATMENT_375,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,987654,NCI Thesaurus,IU/m2,178.0,149.0
SYNTHETIC-1,DONOR_16,TREATMENT_376,Immune checkpoint inhibitors,Tecentriq,987654,NCI Thesaurus,g/m2,157.0,161.0
SYNTHETIC-1,DONOR_17,TREATMENT_377,Cell-based,Venetoclax,278936,NCI Thesaurus,g/m2,133.0,
SYNTHETIC-1,DONOR_18,TREATMENT_378,Immune checkpoint inhibitors,Opdivo,8756456,PubChem,cells/kg,120.0,
SYNTHETIC-1,DONOR_19,TREATMENT_379,,Yervoy,278936,NCI Thesaurus,IU/m2,167.0,196.0
SYNTHETIC-1,DONOR_20,TREATMENT_380,Cell-based,,987654,PubChem,,191.0,
SYNTHETIC-1,DONOR_21,TREATMENT_381,,Braftovi,8836851,PubChem,IU/kg,88.0,191.0
SYNTHETIC-1,DONOR_22,TREATMENT_382,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,PubChem,mg/m2,172.0,173.0
SYNTHETIC-1,DONOR_23,TREATMENT_383,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,4459876,PubChem,IU/m2,,53.0
SYNTHETIC-1,DONOR_24,TREATMENT_384,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,RxNorm,,56.0,176.0
SYNTHETIC-1,DONOR_25,TREATMENT_385,Cell-based,Besponsa,239766,PubChem,cells/kg,105.0,153.0
SYNTHETIC-1,DONOR_26,TREATMENT_386,Immune checkpoint inhibitors,,987654,RxNorm,cells/kg,161.0,190.0
SYNTHETIC-1,DONOR_27,TREATMENT_387,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,,NCI Thesaurus,g/m2,109.0,102.0
SYNTHETIC-1,DONOR_28,TREATMENT_388,Immune checkpoint inhibitors,Nexavar,239766,,g/m2,107.0,140.0
SYNTHETIC-1,DONOR_29,TREATMENT_389,Other immunomodulatory substances,Necitumumab,4459876,RxNorm,ug/m2,147.0,198.0
SYNTHETIC-1,DONOR_30,TREATMENT_390,Immune checkpoint inhibitors,Perjeta,8836851,,cells/kg,192.0,
SYNTHETIC-1,DONOR_31,TREATMENT_391,Immune checkpoint inhibitors,Vemurafenib,8756456,NCI Thesaurus,IU/m2,115.0,110.0
SYNTHETIC-1,DONOR_32,TREATMENT_392,Immune checkpoint inhibitors,Iressa,4459876,,ug/m2,127.0,62.0
SYNTHETIC-1,DONOR_33,TREATMENT_393,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,239766,RxNorm,IU/kg,113.0,90.0
SYNTHETIC-1,DONOR_34,TREATMENT_394,Monoclonal antibodies other than immune checkpoint inhibitors,Mekinist,987654,RxNorm,IU/m2,162.0,
SYNTHETIC-1,DONOR_35,TREATMENT_395,Cell-based,,8756456,NCI Thesaurus,g/m2,66.0,91.0
SYNTHETIC-1,DONOR_36,TREATMENT_396,Immune checkpoint inhibitors,,278936,PubChem,mg/m2,179.0,175.0
SYNTHETIC-1,DONOR_37,TREATMENT_397,Monoclonal antibodies other than immune checkpoint inhibitors,Alectinib,239766,RxNorm,g/m2,101.0,117.0
SYNTHETIC-1,DONOR_38,TREATMENT_398,Cell-based,Xalkori,4459876,NCI Thesaurus,,122.0,189.0
SYNTHETIC-1,DONOR_39,TREATMENT_399,Other immunomodulatory substances,Gilotrif,4459876,RxNorm,IU/kg,186.0,108.0
SYNTHETIC-1,DONOR_40,TREATMENT_400,,Atezolizumab,4459876,RxNorm,mg/m2,111.0,98.0
SYNTHETIC-1,DONOR_1,TREATMENT_321,Cell-based,Vandetanib,4459876,PubChem,IU/m2,66.0,148.0
SYNTHETIC-1,DONOR_2,TREATMENT_322,Immune checkpoint inhibitors,Enhertu,8836851,NCI Thesaurus,mg/m2,,159.0
SYNTHETIC-1,DONOR_3,TREATMENT_323,Other immunomodulatory substances,Venclexta,239766,RxNorm,mg/kg,166.0,157.0
SYNTHETIC-1,DONOR_4,TREATMENT_324,Immune checkpoint inhibitors,Nivolumab,8756456,PubChem,mg/kg,,184.0
SYNTHETIC-1,DONOR_5,TREATMENT_325,Cell-based,,278936,PubChem,IU/m2,101.0,180.0
SYNTHETIC-1,DONOR_6,TREATMENT_326,Cell-based,Atezolizumab,8836851,,mg/m2,84.0,118.0
SYNTHETIC-1,DONOR_7,TREATMENT_327,Other immunomodulatory substances,Dabrafenib,987654,NCI Thesaurus,cells/kg,170.0,147.0
SYNTHETIC-1,DONOR_8,TREATMENT_328,Cell-based,Mekinist,8836851,PubChem,IU/m2,,62.0
SYNTHETIC-1,DONOR_9,TREATMENT_329,Other immunomodulatory substances,Mekinist,8836851,,cells/kg,72.0,
SYNTHETIC-1,DONOR_10,TREATMENT_330,Cell-based,Imfinzi,8756456,RxNorm,ug/m2,186.0,50.0
SYNTHETIC-1,DONOR_11,TREATMENT_331,,Pembrolizumab,987654,NCI Thesaurus,ug/m2,62.0,69.0
SYNTHETIC-1,DONOR_12,TREATMENT_332,Immune checkpoint inhibitors,Enhertu,239766,PubChem,mg/kg,64.0,169.0
SYNTHETIC-1,DONOR_13,TREATMENT_333,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,987654,PubChem,cells/kg,85.0,
SYNTHETIC-1,DONOR_14,TREATMENT_334,,Pexidartinib,,,cells/kg,106.0,173.0
SYNTHETIC-1,DONOR_15,TREATMENT_335,,Ibrance,8756456,NCI Thesaurus,ug/m2,143.0,145.0
SYNTHETIC-1,DONOR_16,TREATMENT_336,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,,NCI Thesaurus,mg/kg,186.0,130.0
SYNTHETIC-1,DONOR_17,TREATMENT_337,Other immunomodulatory substances,,239766,PubChem,IU/m2,72.0,165.0
SYNTHETIC-1,DONOR_18,TREATMENT_338,Cell-based,Ribociclib,,NCI Thesaurus,ug/m2,96.0,166.0
SYNTHETIC-1,DONOR_19,TREATMENT_339,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,8756456,RxNorm,mg/m2,84.0,158.0
SYNTHETIC-1,DONOR_20,TREATMENT_340,Cell-based,Pembrolizumab,8836851,NCI Thesaurus,IU/m2,98.0,157.0
SYNTHETIC-1,DONOR_21,TREATMENT_341,,,239766,RxNorm,IU/m2,92.0,
SYNTHETIC-1,DONOR_22,TREATMENT_342,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,8836851,,g/m2,162.0,92.0
SYNTHETIC-1,DONOR_23,TREATMENT_343,Monoclonal antibodies other than immune checkpoint inhibitors,Ceritinib,278936,NCI Thesaurus,IU/m2,186.0,162.0
SYNTHETIC-1,DONOR_24,TREATMENT_344,,Nivolumab,8756456,RxNorm,IU/kg,190.0,
SYNTHETIC-1,DONOR_25,TREATMENT_345,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,8836851,PubChem,IU/kg,127.0,161.0
SYNTHETIC-1,DONOR_26,TREATMENT_346,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,RxNorm,IU/kg,125.0,128.0
SYNTHETIC-1,DONOR_27,TREATMENT_347,Cell-based,Yescarta,4459876,PubChem,IU/kg,,50.0
SYNTHETIC-1,DONOR_28,TREATMENT_348,Cell-based,Copanlisib,8836851,PubChem,,,160.0
SYNTHETIC-1,DONOR_29,TREATMENT_349,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,987654,PubChem,mg/kg,184.0,89.0
SYNTHETIC-1,DONOR_30,TREATMENT_350,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8836851,,IU/kg,,101.0
SYNTHETIC-1,DONOR_31,TREATMENT_351,Immune checkpoint inhibitors,Xalkori,987654,RxNorm,ug/m2,,178.0
SYNTHETIC-1,DONOR_32,TREATMENT_352,Cell-based,Yescarta,8836851,RxNorm,IU/m2,138.0,150.0
SYNTHETIC-1,DONOR_33,TREATMENT_353,Immune checkpoint inhibitors,Tarceva,8836851,RxNorm,ug/m2,,
SYNTHETIC-1,DONOR_34,TREATMENT_354,Immune checkpoint inhibitors,Nivolumab,8756456,NCI Thesaurus,cells/kg,,96.0
SYNTHETIC-1,DONOR_35,TREATMENT_355,,Erlotinib,4459876,PubChem,mg/kg,93.0,
SYNTHETIC-1,DONOR_36,TREATMENT_356,Other immunomodulatory substances,Pembrolizumab,4459876,PubChem,IU/kg,69.0,72.0
SYNTHETIC-1,DONOR_37,TREATMENT_357,Immune checkpoint inhibitors,Selumitinib,,PubChem,ug/m2,,
SYNTHETIC-1,DONOR_38,TREATMENT_358,Immune checkpoint inhibitors,Trastuzumab,8836851,PubChem,mg/kg,,51.0
SYNTHETIC-1,DONOR_39,TREATMENT_359,Immune checkpoint inhibitors,Osimertinib,,NCI Thesaurus,mg/kg,148.0,79.0
SYNTHETIC-1,DONOR_40,TREATMENT_360,Cell-based,Durvalumab,8756456,RxNorm,ug/m2,96.0,184.0
SYNTHETIC-1,DONOR_1,TREATMENT_361,,Sorafenib,4459876,RxNorm,IU/kg,96.0,173.0
SYNTHETIC-1,DONOR_2,TREATMENT_362,Monoclonal antibodies other than immune checkpoint inhibitors,Ribociclib,8756456,PubChem,g/m2,138.0,107.0
SYNTHETIC-1,DONOR_3,TREATMENT_363,Cell-based,,4459876,,cells/kg,,77.0
SYNTHETIC-1,DONOR_4,TREATMENT_364,Other immunomodulatory substances,Ipilimumab,278936,NCI Thesaurus,IU/m2,155.0,134.0
SYNTHETIC-1,DONOR_5,TREATMENT_365,Cell-based,,8836851,RxNorm,mg/kg,129.0,189.0
SYNTHETIC-1,DONOR_6,TREATMENT_366,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,8756456,RxNorm,mg/kg,139.0,143.0
SYNTHETIC-1,DONOR_7,TREATMENT_367,Cell-based,Encorafenib,8756456,,mg/kg,123.0,113.0
SYNTHETIC-1,DONOR_8,TREATMENT_368,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,278936,RxNorm,,158.0,83.0
SYNTHETIC-1,DONOR_9,TREATMENT_369,Cell-based,Brigatinib,8756456,NCI Thesaurus,cells/kg,101.0,111.0
SYNTHETIC-1,DONOR_10,TREATMENT_370,,Braftovi,4459876,NCI Thesaurus,cells/kg,90.0,56.0
SYNTHETIC-1,DONOR_11,TREATMENT_371,Other immunomodulatory substances,Verzenio,4459876,NCI Thesaurus,cells/kg,109.0,87.0
SYNTHETIC-1,DONOR_12,TREATMENT_372,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,8836851,RxNorm,IU/m2,108.0,52.0
SYNTHETIC-1,DONOR_13,TREATMENT_373,Immune checkpoint inhibitors,Obinutuzumab,987654,NCI Thesaurus,IU/kg,,161.0
SYNTHETIC-1,DONOR_14,TREATMENT_374,Immune checkpoint inhibitors,Keytruda,239766,,,50.0,
SYNTHETIC-1,DONOR_15,TREATMENT_375,Cell-based,Atezolizumab,278936,RxNorm,cells/kg,,
SYNTHETIC-1,DONOR_16,TREATMENT_376,Immune checkpoint inhibitors,Blincyto,987654,RxNorm,,86.0,85.0
SYNTHETIC-1,DONOR_17,TREATMENT_377,Immune checkpoint inhibitors,Nivolumab,4459876,PubChem,,181.0,87.0
SYNTHETIC-1,DONOR_18,TREATMENT_378,Monoclonal antibodies other than immune checkpoint inhibitors,Axicabtagene ciloleucel,987654,PubChem,ug/m2,176.0,176.0
SYNTHETIC-1,DONOR_19,TREATMENT_379,,Verzenio,8836851,RxNorm,IU/kg,109.0,134.0
SYNTHETIC-1,DONOR_20,TREATMENT_380,Immune checkpoint inhibitors,Sorafenib,,,cells/kg,68.0,
SYNTHETIC-1,DONOR_21,TREATMENT_381,Immune checkpoint inhibitors,Sorafenib,4459876,RxNorm,,185.0,140.0
SYNTHETIC-1,DONOR_22,TREATMENT_382,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,4459876,RxNorm,g/m2,79.0,116.0
SYNTHETIC-1,DONOR_23,TREATMENT_383,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,4459876,PubChem,cells/kg,76.0,95.0
SYNTHETIC-1,DONOR_24,TREATMENT_384,Cell-based,Gilotrif,8836851,RxNorm,IU/kg,153.0,160.0
SYNTHETIC-1,DONOR_25,TREATMENT_385,Other immunomodulatory substances,Ceritinib,278936,PubChem,ug/m2,67.0,94.0
SYNTHETIC-1,DONOR_26,TREATMENT_386,Other immunomodulatory substances,Encorafenib,278936,,mg/m2,104.0,
SYNTHETIC-1,DONOR_27,TREATMENT_387,Cell-based,Tecentriq,239766,RxNorm,mg/m2,149.0,177.0
SYNTHETIC-1,DONOR_28,TREATMENT_388,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,987654,RxNorm,ug/m2,,107.0
SYNTHETIC-1,DONOR_29,TREATMENT_389,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,mg/kg,,66.0
SYNTHETIC-1,DONOR_30,TREATMENT_390,Other immunomodulatory substances,Olaparib,4459876,NCI Thesaurus,mg/kg,89.0,98.0
SYNTHETIC-1,DONOR_31,TREATMENT_391,Immune checkpoint inhibitors,,,NCI Thesaurus,IU/m2,,129.0
SYNTHETIC-1,DONOR_32,TREATMENT_392,Immune checkpoint inhibitors,,239766,RxNorm,mg/m2,,
SYNTHETIC-1,DONOR_33,TREATMENT_393,Monoclonal antibodies other than immune checkpoint inhibitors,,,NCI Thesaurus,,115.0,200.0
SYNTHETIC-1,DONOR_34,TREATMENT_394,Monoclonal antibodies other than immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,239766,RxNorm,g/m2,193.0,
SYNTHETIC-1,DONOR_35,TREATMENT_395,Cell-based,Afatinib,4459876,,cells/kg,132.0,127.0
SYNTHETIC-1,DONOR_36,TREATMENT_396,Other immunomodulatory substances,Xalkori,,,ug/m2,,194.0
SYNTHETIC-1,DONOR_37,TREATMENT_397,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,RxNorm,IU/kg,174.0,186.0
SYNTHETIC-1,DONOR_38,TREATMENT_398,Monoclonal antibodies other than immune checkpoint inhibitors,Rucaparib,4459876,,,95.0,159.0
SYNTHETIC-1,DONOR_39,TREATMENT_399,,Dabrafenib,4459876,PubChem,IU/kg,50.0,
SYNTHETIC-1,DONOR_40,TREATMENT_400,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,,g/m2,180.0,93.0
SYNTHETIC-1,DONOR_1,TREATMENT_321,Other immunomodulatory substances,Lenvima,278936,,IU/m2,,
SYNTHETIC-1,DONOR_2,TREATMENT_322,Monoclonal antibodies other than immune checkpoint inhibitors,Selumitinib,4459876,NCI Thesaurus,g/m2,90.0,50.0
SYNTHETIC-1,DONOR_3,TREATMENT_323,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8756456,PubChem,g/m2,64.0,100.0
SYNTHETIC-1,DONOR_4,TREATMENT_324,Cell-based,Fam-trastuzumab deruxtecan-nxki,8836851,NCI Thesaurus,mg/m2,180.0,
SYNTHETIC-1,DONOR_5,TREATMENT_325,Cell-based,Ceritinib,8836851,PubChem,cells/kg,148.0,97.0
SYNTHETIC-1,DONOR_6,TREATMENT_326,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,8756456,NCI Thesaurus,,140.0,162.0
SYNTHETIC-1,DONOR_7,TREATMENT_327,Monoclonal antibodies other than immune checkpoint inhibitors,Niraparib,,PubChem,,57.0,178.0
SYNTHETIC-1,DONOR_8,TREATMENT_328,Other immunomodulatory substances,Ipilimumab,8756456,NCI Thesaurus,ug/m2,137.0,131.0
SYNTHETIC-1,DONOR_9,TREATMENT_329,Immune checkpoint inhibitors,Imfinzi,,RxNorm,mg/m2,75.0,86.0
SYNTHETIC-1,DONOR_10,TREATMENT_330,Cell-based,Tafinlar,8756456,NCI Thesaurus,IU/kg,73.0,185.0
SYNTHETIC-1,DONOR_11,TREATMENT_331,Immune checkpoint inhibitors,Yervoy,239766,PubChem,mg/kg,,112.0
SYNTHETIC-1,DONOR_12,TREATMENT_332,Cell-based,,8836851,RxNorm,mg/kg,,59.0
SYNTHETIC-1,DONOR_13,TREATMENT_333,Cell-based,Encorafenib,278936,RxNorm,mg/kg,131.0,66.0
SYNTHETIC-1,DONOR_14,TREATMENT_334,,Enhertu,4459876,RxNorm,,119.0,67.0
SYNTHETIC-1,DONOR_15,TREATMENT_335,Cell-based,Tecentriq,4459876,PubChem,ug/m2,137.0,147.0
SYNTHETIC-1,DONOR_16,TREATMENT_336,Other immunomodulatory substances,Durvalumab,4459876,,ug/m2,118.0,89.0
SYNTHETIC-1,DONOR_17,TREATMENT_337,,Vemurafenib,8756456,PubChem,mg/m2,161.0,64.0
SYNTHETIC-1,DONOR_18,TREATMENT_338,Other immunomodulatory substances,Opdivo,,PubChem,mg/kg,169.0,59.0
SYNTHETIC-1,DONOR_19,TREATMENT_339,Immune checkpoint inhibitors,Rubraca,278936,,g/m2,177.0,173.0
SYNTHETIC-1,DONOR_20,TREATMENT_340,Other immunomodulatory substances,,,PubChem,IU/m2,122.0,76.0
SYNTHETIC-1,DONOR_21,TREATMENT_341,,Crizotinib,,PubChem,IU/m2,74.0,84.0
SYNTHETIC-1,DONOR_22,TREATMENT_342,Other immunomodulatory substances,Trastuzumab,8756456,NCI Thesaurus,mg/kg,112.0,103.0
SYNTHETIC-1,DONOR_23,TREATMENT_343,Cell-based,Ipilimumab,239766,PubChem,mg/m2,193.0,153.0
SYNTHETIC-1,DONOR_24,TREATMENT_344,Immune checkpoint inhibitors,Trastuzumab,278936,PubChem,mg/kg,,121.0
SYNTHETIC-1,DONOR_25,TREATMENT_345,Immune checkpoint inhibitors,Xalkori,987654,PubChem,ug/m2,166.0,164.0
SYNTHETIC-1,DONOR_26,TREATMENT_346,Immune checkpoint inhibitors,Nivolumab,8836851,NCI Thesaurus,IU/kg,,94.0
SYNTHETIC-1,DONOR_27,TREATMENT_347,Cell-based,Zykadia,278936,RxNorm,mg/kg,115.0,74.0
SYNTHETIC-1,DONOR_28,TREATMENT_348,Cell-based,Nivolumab,239766,NCI Thesaurus,IU/kg,173.0,171.0
SYNTHETIC-1,DONOR_29,TREATMENT_349,Cell-based,Fam-trastuzumab deruxtecan-nxki,239766,RxNorm,g/m2,129.0,99.0
SYNTHETIC-1,DONOR_30,TREATMENT_350,Other immunomodulatory substances,Durvalumab,8836851,NCI Thesaurus,g/m2,,176.0
SYNTHETIC-1,DONOR_31,TREATMENT_351,Cell-based,Ibrance,4459876,,cells/kg,195.0,118.0
SYNTHETIC-1,DONOR_32,TREATMENT_352,Immune checkpoint inhibitors,Pembrolizumab,239766,RxNorm,IU/kg,123.0,105.0
SYNTHETIC-1,DONOR_33,TREATMENT_353,Immune checkpoint inhibitors,Necitumumab,278936,,mg/m2,,85.0
SYNTHETIC-1,DONOR_34,TREATMENT_354,Cell-based,Fam-trastuzumab deruxtecan-nxki,,NCI Thesaurus,cells/kg,199.0,
SYNTHETIC-1,DONOR_35,TREATMENT_355,Other immunomodulatory substances,,239766,,ug/m2,151.0,196.0
SYNTHETIC-1,DONOR_36,TREATMENT_356,Other immunomodulatory substances,Adcetris,,NCI Thesaurus,,,
SYNTHETIC-1,DONOR_37,TREATMENT_357,Cell-based,Afatinib,8756456,NCI Thesaurus,cells/kg,171.0,
SYNTHETIC-1,DONOR_38,TREATMENT_358,,Yervoy,987654,NCI Thesaurus,cells/kg,160.0,198.0
SYNTHETIC-1,DONOR_39,TREATMENT_359,Other immunomodulatory substances,Pembrolizumab,8836851,NCI Thesaurus,IU/kg,159.0,
SYNTHETIC-1,DONOR_40,TREATMENT_360,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,239766,RxNorm,g/m2,132.0,138.0
SYNTHETIC-1,DONOR_1,TREATMENT_361,Cell-based,Atezolizumab,,RxNorm,mg/kg,170.0,
SYNTHETIC-1,DONOR_2,TREATMENT_362,,Tecentriq,239766,NCI Thesaurus,IU/kg,92.0,177.0
SYNTHETIC-1,DONOR_3,TREATMENT_363,Other immunomodulatory substances,Braftovi,8756456,RxNorm,cells/kg,72.0,151.0
SYNTHETIC-1,DONOR_4,TREATMENT_364,Other immunomodulatory substances,Braftovi,239766,NCI Thesaurus,IU/m2,60.0,149.0
SYNTHETIC-1,DONOR_5,TREATMENT_365,Cell-based,Axicabtagene ciloleucel,278936,NCI Thesaurus,IU/m2,154.0,64.0
SYNTHETIC-1,DONOR_6,TREATMENT_366,,Atezolizumab,278936,PubChem,IU/kg,176.0,95.0
SYNTHETIC-1,DONOR_7,TREATMENT_367,Other immunomodulatory substances,Blincyto,,PubChem,IU/kg,111.0,59.0
SYNTHETIC-1,DONOR_8,TREATMENT_368,Cell-based,Nivolumab,8836851,NCI Thesaurus,,194.0,70.0
SYNTHETIC-1,DONOR_9,TREATMENT_369,Immune checkpoint inhibitors,,8836851,,g/m2,76.0,187.0
SYNTHETIC-1,DONOR_10,TREATMENT_370,,Blinatumomab,4459876,NCI Thesaurus,g/m2,52.0,116.0
SYNTHETIC-1,DONOR_11,TREATMENT_371,Immune checkpoint inhibitors,Ipilimumab,4459876,PubChem,IU/kg,,56.0
SYNTHETIC-1,DONOR_12,TREATMENT_372,Monoclonal antibodies other than immune checkpoint inhibitors,Besponsa,8836851,RxNorm,IU/m2,130.0,192.0
SYNTHETIC-1,DONOR_13,TREATMENT_373,,Mekinist,278936,,IU/kg,183.0,89.0
SYNTHETIC-1,DONOR_14,TREATMENT_374,Immune checkpoint inhibitors,,278936,,cells/kg,191.0,99.0
SYNTHETIC-1,DONOR_15,TREATMENT_375,Cell-based,Opdivo,4459876,RxNorm,,91.0,
SYNTHETIC-1,DONOR_16,TREATMENT_376,Cell-based,Nivolumab,,NCI Thesaurus,mg/kg,59.0,55.0
SYNTHETIC-1,DONOR_17,TREATMENT_377,Cell-based,Alunbrig,8756456,,cells/kg,,141.0
SYNTHETIC-1,DONOR_18,TREATMENT_378,,Yervoy,987654,RxNorm,IU/m2,100.0,70.0
SYNTHETIC-1,DONOR_19,TREATMENT_379,Other immunomodulatory substances,,4459876,NCI Thesaurus,g/m2,124.0,
SYNTHETIC-1,DONOR_20,TREATMENT_380,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,PubChem,,,181.0
SYNTHETIC-1,DONOR_21,TREATMENT_381,Other immunomodulatory substances,Tecentriq,,RxNorm,ug/m2,81.0,145.0
SYNTHETIC-1,DONOR_22,TREATMENT_382,Immune checkpoint inhibitors,Tecentriq,,,,157.0,52.0
SYNTHETIC-1,DONOR_23,TREATMENT_383,Other immunomodulatory substances,Besponsa,278936,PubChem,g/m2,141.0,
SYNTHETIC-1,DONOR_24,TREATMENT_384,Cell-based,Venetoclax,8756456,RxNorm,g/m2,,80.0
SYNTHETIC-1,DONOR_25,TREATMENT_385,Cell-based,Tecentriq,4459876,RxNorm,mg/kg,160.0,182.0
SYNTHETIC-1,DONOR_26,TREATMENT_386,Monoclonal antibodies other than immune checkpoint inhibitors,Ado-trastuzumab emtansine,4459876,NCI Thesaurus,mg/kg,76.0,
SYNTHETIC-1,DONOR_27,TREATMENT_387,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,278936,PubChem,mg/m2,75.0,85.0
SYNTHETIC-1,DONOR_28,TREATMENT_388,Immune checkpoint inhibitors,Yervoy,,RxNorm,IU/kg,,200.0
SYNTHETIC-1,DONOR_29,TREATMENT_389,,Durvalumab,239766,,ug/m2,,120.0
SYNTHETIC-1,DONOR_30,TREATMENT_390,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,cells/kg,155.0,197.0
SYNTHETIC-1,DONOR_31,TREATMENT_391,Immune checkpoint inhibitors,Lenvima,8756456,RxNorm,mg/kg,103.0,132.0
SYNTHETIC-1,DONOR_32,TREATMENT_392,,Tagrisso,278936,PubChem,mg/m2,108.0,121.0
SYNTHETIC-1,DONOR_33,TREATMENT_393,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,8836851,NCI Thesaurus,cells/kg,117.0,62.0
SYNTHETIC-1,DONOR_34,TREATMENT_394,Immune checkpoint inhibitors,Opdivo,278936,PubChem,mg/kg,,169.0
SYNTHETIC-1,DONOR_35,TREATMENT_395,Immune checkpoint inhibitors,,239766,,mg/kg,66.0,
SYNTHETIC-1,DONOR_36,TREATMENT_396,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,ug/m2,60.0,176.0
SYNTHETIC-1,DONOR_37,TREATMENT_397,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,278936,NCI Thesaurus,IU/m2,,137.0
SYNTHETIC-1,DONOR_38,TREATMENT_398,Immune checkpoint inhibitors,Adcetris,4459876,PubChem,cells/kg,62.0,114.0
SYNTHETIC-1,DONOR_39,TREATMENT_399,Cell-based,Cometriq,8836851,,IU/kg,118.0,161.0
SYNTHETIC-1,DONOR_40,TREATMENT_400,,,278936,PubChem,ug/m2,75.0,56.0
SYNTHETIC-1,DONOR_1,TREATMENT_321,,Yescarta,,PubChem,mg/m2,69.0,131.0
SYNTHETIC-1,DONOR_2,TREATMENT_322,Cell-based,Sorafenib,,,,67.0,99.0
SYNTHETIC-1,DONOR_3,TREATMENT_323,Other immunomodulatory substances,Nivolumab,8836851,NCI Thesaurus,mg/kg,140.0,73.0
SYNTHETIC-1,DONOR_4,TREATMENT_324,Immune checkpoint inhibitors,Afatinib,8836851,RxNorm,IU/kg,,194.0
SYNTHETIC-1,DONOR_5,TREATMENT_325,,Sorafenib,239766,NCI Thesaurus,,138.0,113.0
SYNTHETIC-1,DONOR_6,TREATMENT_326,Other immunomodulatory substances,Trastuzumab,8836851,,,193.0,158.0
SYNTHETIC-1,DONOR_7,TREATMENT_327,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,RxNorm,mg/kg,183.0,123.0
SYNTHETIC-1,DONOR_8,TREATMENT_328,Cell-based,,4459876,PubChem,cells/kg,188.0,121.0
SYNTHETIC-1,DONOR_9,TREATMENT_329,Immune checkpoint inhibitors,Xalkori,987654,PubChem,IU/kg,,129.0
SYNTHETIC-1,DONOR_10,TREATMENT_330,,Gilteritinib,987654,PubChem,cells/kg,132.0,90.0
SYNTHETIC-1,DONOR_11,TREATMENT_331,Other immunomodulatory substances,Imfinzi,8836851,,mg/kg,157.0,92.0
SYNTHETIC-1,DONOR_12,TREATMENT_332,Cell-based,Zelboraf,8756456,PubChem,IU/m2,105.0,141.0
SYNTHETIC-1,DONOR_13,TREATMENT_333,Monoclonal antibodies other than immune checkpoint inhibitors,Pexidartinib,8836851,PubChem,IU/kg,181.0,179.0
SYNTHETIC-1,DONOR_14,TREATMENT_334,Other immunomodulatory substances,Trastuzumab,8836851,PubChem,IU/m2,,69.0
SYNTHETIC-1,DONOR_15,TREATMENT_335,Immune checkpoint inhibitors,Blinatumomab,8836851,NCI Thesaurus,mg/m2,152.0,
SYNTHETIC-1,DONOR_16,TREATMENT_336,Immune checkpoint inhibitors,Alecensa,239766,,mg/kg,148.0,89.0
SYNTHETIC-1,DONOR_17,TREATMENT_337,Other immunomodulatory substances,Gefitinib,987654,PubChem,,179.0,80.0
SYNTHETIC-1,DONOR_18,TREATMENT_338,,Niraparib,987654,PubChem,g/m2,150.0,
SYNTHETIC-1,DONOR_19,TREATMENT_339,Other immunomodulatory substances,Brigatinib,8756456,NCI Thesaurus,,164.0,
SYNTHETIC-1,DONOR_20,TREATMENT_340,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,987654,NCI Thesaurus,mg/m2,,194.0
SYNTHETIC-1,DONOR_21,TREATMENT_341,Other immunomodulatory substances,Niraparib,239766,NCI Thesaurus,g/m2,91.0,190.0
SYNTHETIC-1,DONOR_22,TREATMENT_342,Other immunomodulatory substances,Tecentriq,8836851,PubChem,,107.0,135.0
SYNTHETIC-1,DONOR_23,TREATMENT_343,Other immunomodulatory substances,Rucaparib,8836851,RxNorm,ug/m2,52.0,196.0
SYNTHETIC-1,DONOR_24,TREATMENT_344,Other immunomodulatory substances,Copanlisib,8756456,PubChem,mg/m2,147.0,
SYNTHETIC-1,DONOR_25,TREATMENT_345,,Tafinlar,,NCI Thesaurus,IU/m2,112.0,150.0
SYNTHETIC-1,DONOR_26,TREATMENT_346,Cell-based,,987654,RxNorm,IU/kg,76.0,135.0
SYNTHETIC-1,DONOR_27,TREATMENT_347,Other immunomodulatory substances,Adcetris,987654,RxNorm,mg/kg,95.0,72.0
SYNTHETIC-1,DONOR_28,TREATMENT_348,Monoclonal antibodies other than immune checkpoint inhibitors,Brigatinib,987654,,g/m2,182.0,
SYNTHETIC-1,DONOR_29,TREATMENT_349,Immune checkpoint inhibitors,Zykadia,,RxNorm,ug/m2,,175.0
SYNTHETIC-1,DONOR_30,TREATMENT_350,Cell-based,Perjeta,987654,RxNorm,mg/m2,75.0,140.0
SYNTHETIC-1,DONOR_31,TREATMENT_351,Immune checkpoint inhibitors,Pexidartinib,239766,NCI Thesaurus,IU/m2,54.0,121.0
SYNTHETIC-1,DONOR_32,TREATMENT_352,Immune checkpoint inhibitors,,239766,RxNorm,ug/m2,62.0,198.0
SYNTHETIC-1,DONOR_33,TREATMENT_353,Monoclonal antibodies other than immune checkpoint inhibitors,Dabrafenib,4459876,PubChem,mg/m2,63.0,189.0
SYNTHETIC-1,DONOR_34,TREATMENT_354,Immune checkpoint inhibitors,Durvalumab,,NCI Thesaurus,cells/kg,54.0,93.0
SYNTHETIC-1,DONOR_35,TREATMENT_355,Other immunomodulatory substances,Rituximab,987654,RxNorm,,152.0,
SYNTHETIC-1,DONOR_36,TREATMENT_356,Cell-based,Durvalumab,278936,NCI Thesaurus,mg/kg,107.0,181.0
SYNTHETIC-1,DONOR_37,TREATMENT_357,,Binimetinib,4459876,NCI Thesaurus,mg/kg,143.0,185.0
SYNTHETIC-1,DONOR_38,TREATMENT_358,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,,IU/m2,97.0,191.0
SYNTHETIC-1,DONOR_39,TREATMENT_359,Other immunomodulatory substances,Iressa,4459876,RxNorm,cells/kg,76.0,180.0
SYNTHETIC-1,DONOR_40,TREATMENT_360,Cell-based,Besponsa,278936,,cells/kg,196.0,
SYNTHETIC-1,DONOR_1,TREATMENT_361,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,239766,RxNorm,cells/kg,57.0,192.0
SYNTHETIC-1,DONOR_2,TREATMENT_362,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,239766,PubChem,ug/m2,186.0,114.0
SYNTHETIC-1,DONOR_3,TREATMENT_363,Cell-based,Kymriah,4459876,NCI Thesaurus,cells/kg,,174.0
SYNTHETIC-1,DONOR_4,TREATMENT_364,,Kymriah,278936,PubChem,mg/kg,129.0,183.0
SYNTHETIC-1,DONOR_5,TREATMENT_365,Cell-based,Kymriah,4459876,PubChem,g/m2,51.0,
SYNTHETIC-1,DONOR_6,TREATMENT_366,Immune checkpoint inhibitors,Gilteritinib,278936,PubChem,cells/kg,83.0,113.0
SYNTHETIC-1,DONOR_7,TREATMENT_367,Immune checkpoint inhibitors,Kisqali,,NCI Thesaurus,ug/m2,124.0,70.0
SYNTHETIC-1,DONOR_8,TREATMENT_368,Other immunomodulatory substances,,239766,NCI Thesaurus,IU/m2,140.0,167.0
SYNTHETIC-1,DONOR_9,TREATMENT_369,Immune checkpoint inhibitors,Vemurafenib,239766,NCI Thesaurus,mg/m2,,95.0
SYNTHETIC-1,DONOR_10,TREATMENT_370,Monoclonal antibodies other than immune checkpoint inhibitors,Gilotrif,8836851,NCI Thesaurus,mg/m2,,74.0
SYNTHETIC-1,DONOR_11,TREATMENT_371,Immune checkpoint inhibitors,Copanlisib,8836851,,ug/m2,200.0,80.0
SYNTHETIC-1,DONOR_12,TREATMENT_372,Immune checkpoint inhibitors,Iressa,,RxNorm,,56.0,191.0
SYNTHETIC-1,DONOR_13,TREATMENT_373,Other immunomodulatory substances,Gefitinib,,PubChem,cells/kg,57.0,
SYNTHETIC-1,DONOR_14,TREATMENT_374,Monoclonal antibodies other than immune checkpoint inhibitors,Imfinzi,8836851,,cells/kg,51.0,101.0
SYNTHETIC-1,DONOR_15,TREATMENT_375,Monoclonal antibodies other than immune checkpoint inhibitors,Trastuzumab,278936,RxNorm,mg/m2,73.0,117.0
SYNTHETIC-1,DONOR_16,TREATMENT_376,Cell-based,Imfinzi,,NCI Thesaurus,ug/m2,79.0,164.0
SYNTHETIC-1,DONOR_17,TREATMENT_377,Immune checkpoint inhibitors,Yervoy,,PubChem,ug/m2,145.0,167.0
SYNTHETIC-1,DONOR_18,TREATMENT_378,Cell-based,Keytruda,239766,PubChem,g/m2,107.0,
SYNTHETIC-1,DONOR_19,TREATMENT_379,Monoclonal antibodies other than immune checkpoint inhibitors,Palbociclib,278936,NCI Thesaurus,mg/kg,70.0,107.0
SYNTHETIC-1,DONOR_20,TREATMENT_380,,Alectinib,987654,NCI Thesaurus,cells/kg,51.0,
SYNTHETIC-1,DONOR_21,TREATMENT_381,,Tafinlar,8836851,NCI Thesaurus,IU/kg,100.0,
SYNTHETIC-1,DONOR_22,TREATMENT_382,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,8756456,RxNorm,ug/m2,178.0,80.0
SYNTHETIC-1,DONOR_23,TREATMENT_383,Other immunomodulatory substances,Alunbrig,278936,PubChem,,87.0,136.0
SYNTHETIC-1,DONOR_24,TREATMENT_384,Immune checkpoint inhibitors,Nivolumab,8756456,,,55.0,170.0
SYNTHETIC-1,DONOR_25,TREATMENT_385,Monoclonal antibodies other than immune checkpoint inhibitors,Cotellic,,,mg/m2,121.0,159.0
SYNTHETIC-1,DONOR_26,TREATMENT_386,Other immunomodulatory substances,Durvalumab,,NCI Thesaurus,IU/kg,132.0,175.0
SYNTHETIC-1,DONOR_27,TREATMENT_387,Cell-based,Nivolumab,4459876,PubChem,mg/kg,89.0,
SYNTHETIC-1,DONOR_28,TREATMENT_388,Immune checkpoint inhibitors,Yescarta,4459876,PubChem,IU/kg,87.0,187.0
SYNTHETIC-1,DONOR_29,TREATMENT_389,Cell-based,,278936,PubChem,IU/kg,78.0,121.0
SYNTHETIC-1,DONOR_30,TREATMENT_390,Monoclonal antibodies other than immune checkpoint inhibitors,Binimetinib,8836851,,,65.0,101.0
SYNTHETIC-1,DONOR_31,TREATMENT_391,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,239766,PubChem,mg/m2,78.0,84.0
SYNTHETIC-1,DONOR_32,TREATMENT_392,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,8756456,NCI Thesaurus,IU/kg,110.0,
SYNTHETIC-1,DONOR_33,TREATMENT_393,Immune checkpoint inhibitors,Binimetinib,239766,RxNorm,IU/m2,188.0,190.0
SYNTHETIC-1,DONOR_34,TREATMENT_394,Cell-based,Rituxan,987654,NCI Thesaurus,ug/m2,146.0,172.0
SYNTHETIC-1,DONOR_35,TREATMENT_395,Cell-based,,987654,PubChem,,,197.0
SYNTHETIC-1,DONOR_36,TREATMENT_396,Monoclonal antibodies other than immune checkpoint inhibitors,Venetoclax,987654,NCI Thesaurus,mg/kg,74.0,104.0
SYNTHETIC-1,DONOR_37,TREATMENT_397,Cell-based,Blincyto,,NCI Thesaurus,IU/kg,123.0,73.0
SYNTHETIC-1,DONOR_38,TREATMENT_398,Immune checkpoint inhibitors,Herceptin,8756456,,ug/m2,,
SYNTHETIC-1,DONOR_39,TREATMENT_399,Other immunomodulatory substances,Nivolumab,987654,NCI Thesaurus,,,50.0
SYNTHETIC-1,DONOR_40,TREATMENT_400,Cell-based,Cobimetinib,278936,RxNorm,IU/m2,177.0,183.0
SYNTHETIC-1,DONOR_1,TREATMENT_321,Other immunomodulatory substances,Blincyto,239766,,ug/m2,82.0,183.0
SYNTHETIC-1,DONOR_2,TREATMENT_322,Other immunomodulatory substances,Lynparza,239766,NCI Thesaurus,IU/m2,134.0,194.0
SYNTHETIC-1,DONOR_3,TREATMENT_323,Cell-based,Cometriq,8756456,PubChem,cells/kg,175.0,
SYNTHETIC-1,DONOR_4,TREATMENT_324,Other immunomodulatory substances,Ceritinib,8836851,PubChem,cells/kg,84.0,185.0
SYNTHETIC-1,DONOR_5,TREATMENT_325,Other immunomodulatory substances,Nivolumab,278936,NCI Thesaurus,mg/kg,155.0,65.0
SYNTHETIC-1,DONOR_6,TREATMENT_326,Cell-based,Adcetris,,,IU/kg,60.0,76.0
SYNTHETIC-1,DONOR_7,TREATMENT_327,Cell-based,Dabrafenib,,PubChem,ug/m2,,78.0
SYNTHETIC-1,DONOR_8,TREATMENT_328,Immune checkpoint inhibitors,Ipilimumab,8756456,NCI Thesaurus,ug/m2,117.0,62.0
SYNTHETIC-1,DONOR_9,TREATMENT_329,Cell-based,Sorafenib,8836851,RxNorm,,104.0,
SYNTHETIC-1,DONOR_10,TREATMENT_330,Monoclonal antibodies other than immune checkpoint inhibitors,Rituximab,8836851,RxNorm,mg/m2,185.0,151.0
SYNTHETIC-1,DONOR_11,TREATMENT_331,Other immunomodulatory substances,Axicabtagene ciloleucel,8756456,RxNorm,IU/kg,139.0,91.0
SYNTHETIC-1,DONOR_12,TREATMENT_332,Cell-based,Perjeta,8756456,RxNorm,mg/kg,122.0,133.0
SYNTHETIC-1,DONOR_13,TREATMENT_333,Immune checkpoint inhibitors,Ipilimumab,987654,PubChem,mg/kg,,109.0
SYNTHETIC-1,DONOR_14,TREATMENT_334,Immune checkpoint inhibitors,Palbociclib,278936,PubChem,mg/kg,130.0,
SYNTHETIC-1,DONOR_15,TREATMENT_335,Monoclonal antibodies other than immune checkpoint inhibitors,Necitumumab,4459876,NCI Thesaurus,mg/kg,149.0,
SYNTHETIC-1,DONOR_16,TREATMENT_336,Immune checkpoint inhibitors,Dabrafenib,8756456,RxNorm,g/m2,127.0,168.0
SYNTHETIC-1,DONOR_17,TREATMENT_337,Cell-based,,278936,NCI Thesaurus,mg/kg,,183.0
SYNTHETIC-1,DONOR_18,TREATMENT_338,Immune checkpoint inhibitors,Ibrance,8756456,,mg/kg,151.0,113.0
SYNTHETIC-1,DONOR_19,TREATMENT_339,Other immunomodulatory substances,Selumitinib,987654,NCI Thesaurus,cells/kg,85.0,126.0
SYNTHETIC-1,DONOR_20,TREATMENT_340,Cell-based,,4459876,NCI Thesaurus,mg/m2,120.0,
SYNTHETIC-1,DONOR_21,TREATMENT_341,Other immunomodulatory substances,Niraparib,239766,RxNorm,cells/kg,200.0,127.0
SYNTHETIC-1,DONOR_22,TREATMENT_342,Cell-based,Pexidartinib,239766,NCI Thesaurus,g/m2,,
SYNTHETIC-1,DONOR_23,TREATMENT_343,Monoclonal antibodies other than immune checkpoint inhibitors,,239766,RxNorm,g/m2,125.0,198.0
SYNTHETIC-1,DONOR_24,TREATMENT_344,Immune checkpoint inhibitors,Pembrolizumab,278936,RxNorm,mg/kg,175.0,152.0
SYNTHETIC-1,DONOR_25,TREATMENT_345,Monoclonal antibodies other than immune checkpoint inhibitors,Crizotinib,278936,PubChem,ug/m2,181.0,
SYNTHETIC-1,DONOR_26,TREATMENT_346,Monoclonal antibodies other than immune checkpoint inhibitors,Xalkori,239766,PubChem,mg/m2,,120.0
SYNTHETIC-1,DONOR_27,TREATMENT_347,Immune checkpoint inhibitors,Rituximab,,PubChem,,,146.0
SYNTHETIC-1,DONOR_28,TREATMENT_348,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,ug/m2,115.0,103.0
SYNTHETIC-1,DONOR_29,TREATMENT_349,Cell-based,Ipilimumab,4459876,RxNorm,mg/m2,78.0,168.0
SYNTHETIC-1,DONOR_30,TREATMENT_350,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,239766,NCI Thesaurus,IU/m2,64.0,74.0
SYNTHETIC-1,DONOR_31,TREATMENT_351,Cell-based,Durvalumab,239766,RxNorm,,63.0,102.0
SYNTHETIC-1,DONOR_32,TREATMENT_352,Immune checkpoint inhibitors,Gilotrif,987654,RxNorm,cells/kg,192.0,103.0
SYNTHETIC-1,DONOR_33,TREATMENT_353,,Yervoy,8756456,RxNorm,mg/kg,148.0,
SYNTHETIC-1,DONOR_34,TREATMENT_354,Other immunomodulatory substances,Tagrisso,8836851,RxNorm,mg/kg,,151.0
SYNTHETIC-1,DONOR_35,TREATMENT_355,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,4459876,RxNorm,mg/m2,113.0,82.0
SYNTHETIC-1,DONOR_36,TREATMENT_356,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,,PubChem,IU/m2,,196.0
SYNTHETIC-1,DONOR_37,TREATMENT_357,Cell-based,Nivolumab,278936,NCI Thesaurus,ug/m2,159.0,173.0
SYNTHETIC-1,DONOR_38,TREATMENT_358,Cell-based,Enhertu,8836851,PubChem,mg/kg,75.0,106.0
SYNTHETIC-1,DONOR_39,TREATMENT_359,Cell-based,Blinatumomab,4459876,RxNorm,IU/m2,80.0,81.0
SYNTHETIC-1,DONOR_40,TREATMENT_360,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,8756456,NCI Thesaurus,IU/m2,,135.0
SYNTHETIC-1,DONOR_1,TREATMENT_361,Immune checkpoint inhibitors,Imfinzi,239766,PubChem,ug/m2,,108.0
SYNTHETIC-1,DONOR_2,TREATMENT_362,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,8836851,NCI Thesaurus,g/m2,107.0,115.0
SYNTHETIC-1,DONOR_3,TREATMENT_363,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,8836851,PubChem,mg/m2,146.0,190.0
SYNTHETIC-1,DONOR_4,TREATMENT_364,,Durvalumab,,NCI Thesaurus,,118.0,104.0
SYNTHETIC-1,DONOR_5,TREATMENT_365,Other immunomodulatory substances,Xalkori,4459876,NCI Thesaurus,g/m2,97.0,
SYNTHETIC-1,DONOR_6,TREATMENT_366,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,NCI Thesaurus,g/m2,114.0,61.0
SYNTHETIC-1,DONOR_7,TREATMENT_367,Immune checkpoint inhibitors,,239766,PubChem,cells/kg,,51.0
SYNTHETIC-1,DONOR_8,TREATMENT_368,Other immunomodulatory substances,Tisagenlecleucel,4459876,,IU/m2,145.0,
SYNTHETIC-1,DONOR_9,TREATMENT_369,Cell-based,Brentuximab vedotin,4459876,PubChem,cells/kg,100.0,83.0
SYNTHETIC-1,DONOR_10,TREATMENT_370,Other immunomodulatory substances,Pembrolizumab,278936,NCI Thesaurus,mg/kg,,85.0
SYNTHETIC-1,DONOR_11,TREATMENT_371,Cell-based,Atezolizumab,987654,NCI Thesaurus,IU/kg,81.0,182.0
SYNTHETIC-1,DONOR_12,TREATMENT_372,Other immunomodulatory substances,Ibrance,8756456,RxNorm,mg/kg,86.0,181.0
SYNTHETIC-1,DONOR_13,TREATMENT_373,Cell-based,,987654,RxNorm,,83.0,169.0
SYNTHETIC-1,DONOR_14,TREATMENT_374,Other immunomodulatory substances,Rubraca,8836851,,g/m2,66.0,
SYNTHETIC-1,DONOR_15,TREATMENT_375,Cell-based,Keytruda,239766,PubChem,IU/kg,192.0,117.0
SYNTHETIC-1,DONOR_16,TREATMENT_376,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,4459876,RxNorm,mg/kg,56.0,110.0
SYNTHETIC-1,DONOR_17,TREATMENT_377,Other immunomodulatory substances,Tecentriq,,PubChem,g/m2,,121.0
SYNTHETIC-1,DONOR_18,TREATMENT_378,Immune checkpoint inhibitors,Fam-trastuzumab deruxtecan-nxki,8836851,PubChem,,65.0,
SYNTHETIC-1,DONOR_19,TREATMENT_379,Other immunomodulatory substances,Perjeta,8836851,,,107.0,125.0
SYNTHETIC-1,DONOR_20,TREATMENT_380,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,4459876,NCI Thesaurus,mg/m2,93.0,188.0
SYNTHETIC-1,DONOR_21,TREATMENT_381,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,239766,,,,
SYNTHETIC-1,DONOR_22,TREATMENT_382,Immune checkpoint inhibitors,Keytruda,8756456,NCI Thesaurus,IU/m2,136.0,162.0
SYNTHETIC-1,DONOR_23,TREATMENT_383,Immune checkpoint inhibitors,Venetoclax,,RxNorm,cells/kg,134.0,178.0
SYNTHETIC-1,DONOR_24,TREATMENT_384,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,239766,NCI Thesaurus,IU/kg,82.0,179.0
SYNTHETIC-1,DONOR_25,TREATMENT_385,Immune checkpoint inhibitors,Obinutuzumab,,NCI Thesaurus,,149.0,67.0
SYNTHETIC-1,DONOR_26,TREATMENT_386,Immune checkpoint inhibitors,Necitumumab,8836851,NCI Thesaurus,IU/m2,154.0,
SYNTHETIC-1,DONOR_27,TREATMENT_387,Immune checkpoint inhibitors,Binimetinib,,RxNorm,,95.0,132.0
SYNTHETIC-1,DONOR_28,TREATMENT_388,Monoclonal antibodies other than immune checkpoint inhibitors,Lynparza,4459876,PubChem,cells/kg,93.0,153.0
SYNTHETIC-1,DONOR_29,TREATMENT_389,Other immunomodulatory substances,Zejula,8756456,RxNorm,ug/m2,62.0,113.0
SYNTHETIC-1,DONOR_30,TREATMENT_390,Other immunomodulatory substances,Pexidartinib,278936,RxNorm,mg/m2,146.0,110.0
SYNTHETIC-1,DONOR_31,TREATMENT_391,Cell-based,,239766,PubChem,IU/m2,144.0,191.0
SYNTHETIC-1,DONOR_32,TREATMENT_392,Monoclonal antibodies other than immune checkpoint inhibitors,Alunbrig,4459876,,,195.0,85.0
SYNTHETIC-1,DONOR_33,TREATMENT_393,Immune checkpoint inhibitors,Xalkori,4459876,,g/m2,129.0,167.0
SYNTHETIC-1,DONOR_34,TREATMENT_394,Monoclonal antibodies other than immune checkpoint inhibitors,Cabozantinib,4459876,RxNorm,,96.0,130.0
SYNTHETIC-1,DONOR_35,TREATMENT_395,Cell-based,Gilteritinib,8836851,NCI Thesaurus,mg/m2,125.0,170.0
SYNTHETIC-1,DONOR_36,TREATMENT_396,Cell-based,,987654,NCI Thesaurus,mg/m2,188.0,107.0
SYNTHETIC-1,DONOR_37,TREATMENT_397,Monoclonal antibodies other than immune checkpoint inhibitors,Braftovi,8836851,RxNorm,mg/m2,130.0,191.0
SYNTHETIC-1,DONOR_38,TREATMENT_398,Other immunomodulatory substances,Trastuzumab,278936,NCI Thesaurus,IU/kg,69.0,115.0
SYNTHETIC-1,DONOR_39,TREATMENT_399,Cell-based,Brentuximab vedotin,8756456,,IU/m2,177.0,
SYNTHETIC-1,DONOR_40,TREATMENT_400,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,987654,RxNorm,mg/m2,121.0,77.0
SYNTHETIC-1,DONOR_1,TREATMENT_321,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,4459876,,cells/kg,,93.0
SYNTHETIC-1,DONOR_2,TREATMENT_322,,Abemaciclib,4459876,PubChem,g/m2,111.0,187.0
SYNTHETIC-1,DONOR_3,TREATMENT_323,Monoclonal antibodies other than immune checkpoint inhibitors,Durvalumab,987654,PubChem,,162.0,137.0
SYNTHETIC-1,DONOR_4,TREATMENT_324,Other immunomodulatory substances,,,,g/m2,75.0,154.0
SYNTHETIC-1,DONOR_5,TREATMENT_325,,Crizotinib,278936,RxNorm,IU/m2,104.0,175.0
SYNTHETIC-1,DONOR_6,TREATMENT_326,Immune checkpoint inhibitors,Palbociclib,8836851,PubChem,mg/m2,183.0,104.0
SYNTHETIC-1,DONOR_7,TREATMENT_327,Cell-based,Tecentriq,278936,PubChem,mg/kg,150.0,102.0
SYNTHETIC-1,DONOR_8,TREATMENT_328,Other immunomodulatory substances,Daratumumab,987654,PubChem,mg/m2,,89.0
SYNTHETIC-1,DONOR_9,TREATMENT_329,Cell-based,Ipilimumab,8836851,RxNorm,,62.0,104.0
SYNTHETIC-1,DONOR_10,TREATMENT_330,Other immunomodulatory substances,Durvalumab,4459876,RxNorm,cells/kg,159.0,194.0
SYNTHETIC-1,DONOR_11,TREATMENT_331,Cell-based,Besponsa,278936,PubChem,mg/kg,,133.0
SYNTHETIC-1,DONOR_12,TREATMENT_332,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,4459876,PubChem,mg/m2,193.0,95.0
SYNTHETIC-1,DONOR_13,TREATMENT_333,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,987654,NCI Thesaurus,ug/m2,145.0,146.0
SYNTHETIC-1,DONOR_14,TREATMENT_334,Monoclonal antibodies other than immune checkpoint inhibitors,Tafinlar,4459876,PubChem,,198.0,61.0
SYNTHETIC-1,DONOR_15,TREATMENT_335,Cell-based,Abemaciclib,278936,PubChem,ug/m2,57.0,88.0
SYNTHETIC-1,DONOR_16,TREATMENT_336,Monoclonal antibodies other than immune checkpoint inhibitors,Rubraca,4459876,RxNorm,IU/kg,,98.0
SYNTHETIC-1,DONOR_17,TREATMENT_337,Immune checkpoint inhibitors,Caprelsa,239766,NCI Thesaurus,,107.0,106.0
SYNTHETIC-1,DONOR_18,TREATMENT_338,Immune checkpoint inhibitors,Lynparza,4459876,,g/m2,153.0,145.0
SYNTHETIC-1,DONOR_19,TREATMENT_339,,Ceritinib,987654,RxNorm,IU/m2,187.0,107.0
SYNTHETIC-1,DONOR_20,TREATMENT_340,Immune checkpoint inhibitors,Dabrafenib,278936,PubChem,,185.0,137.0
SYNTHETIC-1,DONOR_21,TREATMENT_341,Cell-based,,987654,,,103.0,
SYNTHETIC-1,DONOR_22,TREATMENT_342,,Selumitinib,987654,NCI Thesaurus,g/m2,75.0,108.0
SYNTHETIC-1,DONOR_23,TREATMENT_343,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,,,
SYNTHETIC-1,DONOR_24,TREATMENT_344,,,8836851,RxNorm,mg/m2,,66.0
SYNTHETIC-1,DONOR_25,TREATMENT_345,Cell-based,Tecentriq,,PubChem,IU/kg,138.0,
SYNTHETIC-1,DONOR_26,TREATMENT_346,,Axicabtagene ciloleucel,239766,PubChem,ug/m2,,74.0
SYNTHETIC-1,DONOR_27,TREATMENT_347,Cell-based,Durvalumab,8756456,PubChem,g/m2,,171.0
SYNTHETIC-1,DONOR_28,TREATMENT_348,Immune checkpoint inhibitors,Cobimetinib,8756456,PubChem,ug/m2,66.0,61.0
SYNTHETIC-1,DONOR_29,TREATMENT_349,Other immunomodulatory substances,Opdivo,987654,PubChem,cells/kg,128.0,
SYNTHETIC-1,DONOR_30,TREATMENT_350,Immune checkpoint inhibitors,,8836851,RxNorm,mg/kg,191.0,166.0
SYNTHETIC-1,DONOR_31,TREATMENT_351,Cell-based,,239766,NCI Thesaurus,mg/kg,142.0,174.0
SYNTHETIC-1,DONOR_32,TREATMENT_352,Immune checkpoint inhibitors,Gilotrif,987654,NCI Thesaurus,mg/m2,85.0,
SYNTHETIC-1,DONOR_33,TREATMENT_353,Immune checkpoint inhibitors,Blincyto,987654,NCI Thesaurus,ug/m2,,150.0
SYNTHETIC-1,DONOR_34,TREATMENT_354,Cell-based,Tecentriq,8836851,,IU/m2,175.0,73.0
SYNTHETIC-1,DONOR_35,TREATMENT_355,Other immunomodulatory substances,Vemurafenib,4459876,NCI Thesaurus,ug/m2,,
SYNTHETIC-1,DONOR_36,TREATMENT_356,Other immunomodulatory substances,Ribociclib,987654,,g/m2,179.0,184.0
SYNTHETIC-1,DONOR_37,TREATMENT_357,Monoclonal antibodies other than immune checkpoint inhibitors,Venetoclax,987654,RxNorm,g/m2,87.0,181.0
SYNTHETIC-1,DONOR_38,TREATMENT_358,Immune checkpoint inhibitors,Afatinib,8756456,PubChem,,136.0,67.0
SYNTHETIC-1,DONOR_39,TREATMENT_359,,Yervoy,278936,RxNorm,g/m2,57.0,94.0
SYNTHETIC-1,DONOR_40,TREATMENT_360,Cell-based,Tecentriq,987654,RxNorm,,51.0,
SYNTHETIC-1,DONOR_1,TREATMENT_361,Immune checkpoint inhibitors,Encorafenib,239766,PubChem,IU/m2,193.0,195.0
SYNTHETIC-1,DONOR_2,TREATMENT_362,Other immunomodulatory substances,Atezolizumab,8756456,PubChem,IU/m2,192.0,72.0
SYNTHETIC-1,DONOR_3,TREATMENT_363,,Inotuzumab ozogamicin,,NCI Thesaurus,cells/kg,161.0,
SYNTHETIC-1,DONOR_4,TREATMENT_364,,Tisagenlecleucel,278936,,mg/kg,192.0,101.0
SYNTHETIC-1,DONOR_5,TREATMENT_365,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,8836851,PubChem,cells/kg,,138.0
SYNTHETIC-1,DONOR_6,TREATMENT_366,,Trametinib,8756456,NCI Thesaurus,,124.0,84.0
SYNTHETIC-1,DONOR_7,TREATMENT_367,Immune checkpoint inhibitors,Iressa,987654,PubChem,cells/kg,140.0,117.0
SYNTHETIC-1,DONOR_8,TREATMENT_368,Immune checkpoint inhibitors,Alectinib,,RxNorm,cells/kg,,194.0
SYNTHETIC-1,DONOR_9,TREATMENT_369,Immune checkpoint inhibitors,Atezolizumab,4459876,RxNorm,IU/kg,96.0,67.0
SYNTHETIC-1,DONOR_10,TREATMENT_370,Immune checkpoint inhibitors,Mekinist,987654,NCI Thesaurus,g/m2,64.0,144.0
SYNTHETIC-1,DONOR_11,TREATMENT_371,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,239766,NCI Thesaurus,cells/kg,,
SYNTHETIC-1,DONOR_12,TREATMENT_372,Immune checkpoint inhibitors,Atezolizumab,278936,NCI Thesaurus,,,54.0
SYNTHETIC-1,DONOR_13,TREATMENT_373,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,239766,RxNorm,g/m2,162.0,50.0
SYNTHETIC-1,DONOR_14,TREATMENT_374,Other immunomodulatory substances,Trastuzumab,8756456,,IU/m2,197.0,115.0
SYNTHETIC-1,DONOR_15,TREATMENT_375,Cell-based,Tarceva,8836851,NCI Thesaurus,mg/m2,144.0,164.0
SYNTHETIC-1,DONOR_16,TREATMENT_376,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,8756456,NCI Thesaurus,mg/m2,,59.0
SYNTHETIC-1,DONOR_17,TREATMENT_377,Monoclonal antibodies other than immune checkpoint inhibitors,Verzenio,4459876,RxNorm,IU/m2,160.0,166.0
SYNTHETIC-1,DONOR_18,TREATMENT_378,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,8836851,RxNorm,cells/kg,140.0,161.0
SYNTHETIC-1,DONOR_19,TREATMENT_379,Cell-based,Encorafenib,,NCI Thesaurus,ug/m2,61.0,200.0
SYNTHETIC-1,DONOR_20,TREATMENT_380,Other immunomodulatory substances,Gefitinib,278936,RxNorm,mg/kg,188.0,57.0
SYNTHETIC-1,DONOR_21,TREATMENT_381,Other immunomodulatory substances,Nivolumab,239766,NCI Thesaurus,,99.0,
SYNTHETIC-1,DONOR_22,TREATMENT_382,Monoclonal antibodies other than immune checkpoint inhibitors,Tecentriq,,PubChem,g/m2,61.0,141.0
SYNTHETIC-1,DONOR_23,TREATMENT_383,Cell-based,Mektovi,239766,,g/m2,93.0,187.0
SYNTHETIC-1,DONOR_24,TREATMENT_384,Monoclonal antibodies other than immune checkpoint inhibitors,Nivolumab,987654,RxNorm,mg/m2,125.0,160.0
SYNTHETIC-1,DONOR_25,TREATMENT_385,Other immunomodulatory substances,Cobimetinib,987654,RxNorm,IU/m2,149.0,120.0
SYNTHETIC-1,DONOR_26,TREATMENT_386,Other immunomodulatory substances,Enhertu,4459876,PubChem,mg/kg,82.0,181.0
SYNTHETIC-1,DONOR_27,TREATMENT_387,,Caprelsa,239766,,mg/kg,125.0,153.0
SYNTHETIC-1,DONOR_28,TREATMENT_388,Cell-based,Ipilimumab,239766,NCI Thesaurus,IU/m2,112.0,154.0
SYNTHETIC-1,DONOR_29,TREATMENT_389,Immune checkpoint inhibitors,Ipilimumab,,PubChem,cells/kg,196.0,140.0
SYNTHETIC-1,DONOR_30,TREATMENT_390,Cell-based,Perjeta,4459876,,mg/kg,86.0,
SYNTHETIC-1,DONOR_31,TREATMENT_391,Other immunomodulatory substances,Imfinzi,239766,,ug/m2,100.0,
SYNTHETIC-1,DONOR_32,TREATMENT_392,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,8756456,NCI Thesaurus,mg/kg,70.0,196.0
SYNTHETIC-1,DONOR_33,TREATMENT_393,Other immunomodulatory substances,Keytruda,239766,NCI Thesaurus,mg/m2,97.0,190.0
SYNTHETIC-1,DONOR_34,TREATMENT_394,Immune checkpoint inhibitors,Vandetanib,239766,NCI Thesaurus,cells/kg,144.0,178.0
SYNTHETIC-1,DONOR_35,TREATMENT_395,Other immunomodulatory substances,Alecensa,8756456,PubChem,IU/m2,75.0,
SYNTHETIC-1,DONOR_36,TREATMENT_396,Immune checkpoint inhibitors,,,RxNorm,mg/kg,,79.0
SYNTHETIC-1,DONOR_37,TREATMENT_397,Immune checkpoint inhibitors,Xalkori,8836851,,mg/kg,,88.0
SYNTHETIC-1,DONOR_38,TREATMENT_398,Cell-based,Yervoy,8756456,,ug/m2,,61.0
SYNTHETIC-1,DONOR_39,TREATMENT_399,Other immunomodulatory substances,Ado-trastuzumab emtansine,8836851,RxNorm,g/m2,189.0,92.0
SYNTHETIC-1,DONOR_40,TREATMENT_400,Immune checkpoint inhibitors,Xalkori,,RxNorm,IU/m2,,120.0
SYNTHETIC-1,DONOR_1,TREATMENT_401,Immune checkpoint inhibitors,Imfinzi,239766,PubChem,IU/kg,,122.0
SYNTHETIC-1,DONOR_2,TREATMENT_402,Monoclonal antibodies other than immune checkpoint inhibitors,Iressa,,RxNorm,mg/m2,88.0,143.0
SYNTHETIC-1,DONOR_3,TREATMENT_403,Cell-based,Osimertinib,8756456,NCI Thesaurus,mg/m2,147.0,
SYNTHETIC-1,DONOR_4,TREATMENT_404,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,4459876,NCI Thesaurus,IU/m2,122.0,50.0
SYNTHETIC-1,DONOR_5,TREATMENT_405,Immune checkpoint inhibitors,Zelboraf,8836851,NCI Thesaurus,mg/m2,181.0,70.0
SYNTHETIC-1,DONOR_6,TREATMENT_406,Other immunomodulatory substances,Trametinib,4459876,RxNorm,mg/kg,155.0,52.0
SYNTHETIC-1,DONOR_7,TREATMENT_407,Other immunomodulatory substances,Cabozantinib,8836851,PubChem,,74.0,106.0
SYNTHETIC-1,DONOR_8,TREATMENT_408,Cell-based,Caprelsa,,RxNorm,mg/m2,89.0,123.0
SYNTHETIC-1,DONOR_9,TREATMENT_409,,Opdivo,8756456,RxNorm,g/m2,180.0,118.0
SYNTHETIC-1,DONOR_10,TREATMENT_410,Monoclonal antibodies other than immune checkpoint inhibitors,Abemaciclib,987654,,ug/m2,178.0,141.0
SYNTHETIC-1,DONOR_11,TREATMENT_411,Immune checkpoint inhibitors,Nivolumab,239766,NCI Thesaurus,,121.0,158.0
SYNTHETIC-1,DONOR_12,TREATMENT_412,Monoclonal antibodies other than immune checkpoint inhibitors,Daratumumab,239766,RxNorm,ug/m2,52.0,
SYNTHETIC-1,DONOR_13,TREATMENT_413,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,239766,RxNorm,cells/kg,80.0,
SYNTHETIC-1,DONOR_14,TREATMENT_414,Other immunomodulatory substances,Erlotinib,,PubChem,,163.0,117.0
SYNTHETIC-1,DONOR_15,TREATMENT_415,,Mektovi,278936,PubChem,cells/kg,,158.0
SYNTHETIC-1,DONOR_16,TREATMENT_416,Other immunomodulatory substances,,239766,RxNorm,,,65.0
SYNTHETIC-1,DONOR_17,TREATMENT_417,,Gazyva,8756456,NCI Thesaurus,cells/kg,53.0,172.0
SYNTHETIC-1,DONOR_18,TREATMENT_418,Immune checkpoint inhibitors,Tecentriq,8756456,PubChem,ug/m2,125.0,57.0
SYNTHETIC-1,DONOR_19,TREATMENT_419,Immune checkpoint inhibitors,Necitumumab,278936,RxNorm,ug/m2,,129.0
SYNTHETIC-1,DONOR_20,TREATMENT_420,Other immunomodulatory substances,Zejula,987654,RxNorm,ug/m2,104.0,114.0
SYNTHETIC-1,DONOR_21,TREATMENT_421,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,278936,NCI Thesaurus,g/m2,178.0,92.0
SYNTHETIC-1,DONOR_22,TREATMENT_422,Cell-based,Tisagenlecleucel,4459876,RxNorm,cells/kg,165.0,
SYNTHETIC-1,DONOR_23,TREATMENT_423,Monoclonal antibodies other than immune checkpoint inhibitors,Kymriah,278936,NCI Thesaurus,,74.0,70.0
SYNTHETIC-1,DONOR_24,TREATMENT_424,Other immunomodulatory substances,Gilotrif,4459876,PubChem,g/m2,,75.0
SYNTHETIC-1,DONOR_25,TREATMENT_425,Immune checkpoint inhibitors,Axicabtagene ciloleucel,8836851,RxNorm,IU/m2,109.0,113.0
SYNTHETIC-1,DONOR_26,TREATMENT_426,Immune checkpoint inhibitors,Rituxan,239766,,cells/kg,120.0,127.0
SYNTHETIC-1,DONOR_27,TREATMENT_427,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,4459876,RxNorm,cells/kg,50.0,89.0
SYNTHETIC-1,DONOR_28,TREATMENT_428,Cell-based,,4459876,RxNorm,mg/m2,183.0,163.0
SYNTHETIC-1,DONOR_29,TREATMENT_429,Immune checkpoint inhibitors,,8756456,PubChem,cells/kg,66.0,138.0
SYNTHETIC-1,DONOR_30,TREATMENT_430,,Tecentriq,8756456,NCI Thesaurus,IU/kg,107.0,119.0
SYNTHETIC-1,DONOR_31,TREATMENT_431,,Binimetinib,8836851,NCI Thesaurus,IU/kg,114.0,88.0
SYNTHETIC-1,DONOR_32,TREATMENT_432,Monoclonal antibodies other than immune checkpoint inhibitors,,8756456,NCI Thesaurus,mg/kg,84.0,53.0
SYNTHETIC-1,DONOR_33,TREATMENT_433,Other immunomodulatory substances,Alectinib,8836851,NCI Thesaurus,IU/m2,73.0,162.0
SYNTHETIC-1,DONOR_34,TREATMENT_434,Other immunomodulatory substances,Ribociclib,8836851,,ug/m2,196.0,72.0
SYNTHETIC-1,DONOR_35,TREATMENT_435,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,NCI Thesaurus,mg/kg,112.0,
SYNTHETIC-1,DONOR_36,TREATMENT_436,Immune checkpoint inhibitors,,,PubChem,mg/m2,118.0,132.0
SYNTHETIC-1,DONOR_37,TREATMENT_437,Immune checkpoint inhibitors,,4459876,PubChem,g/m2,109.0,75.0
SYNTHETIC-1,DONOR_38,TREATMENT_438,Immune checkpoint inhibitors,Yescarta,,NCI Thesaurus,,59.0,103.0
SYNTHETIC-1,DONOR_39,TREATMENT_439,Other immunomodulatory substances,Ceritinib,8756456,PubChem,cells/kg,182.0,177.0
SYNTHETIC-1,DONOR_40,TREATMENT_440,Immune checkpoint inhibitors,,987654,PubChem,cells/kg,173.0,108.0
SYNTHETIC-1,DONOR_1,TREATMENT_401,Immune checkpoint inhibitors,,4459876,PubChem,IU/kg,196.0,52.0
SYNTHETIC-1,DONOR_2,TREATMENT_402,Immune checkpoint inhibitors,,278936,NCI Thesaurus,mg/kg,,80.0
SYNTHETIC-1,DONOR_3,TREATMENT_403,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,4459876,RxNorm,IU/m2,81.0,131.0
SYNTHETIC-1,DONOR_4,TREATMENT_404,Immune checkpoint inhibitors,Kisqali,239766,NCI Thesaurus,g/m2,151.0,187.0
SYNTHETIC-1,DONOR_5,TREATMENT_405,Immune checkpoint inhibitors,Ceritinib,239766,,IU/kg,,124.0
SYNTHETIC-1,DONOR_6,TREATMENT_406,Other immunomodulatory substances,,278936,RxNorm,g/m2,174.0,119.0
SYNTHETIC-1,DONOR_7,TREATMENT_407,Other immunomodulatory substances,Venetoclax,4459876,NCI Thesaurus,g/m2,170.0,
SYNTHETIC-1,DONOR_8,TREATMENT_408,Immune checkpoint inhibitors,Keytruda,8756456,NCI Thesaurus,,77.0,143.0
SYNTHETIC-1,DONOR_9,TREATMENT_409,Cell-based,,,NCI Thesaurus,ug/m2,185.0,136.0
SYNTHETIC-1,DONOR_10,TREATMENT_410,Cell-based,Tisagenlecleucel,4459876,RxNorm,IU/kg,112.0,158.0
SYNTHETIC-1,DONOR_11,TREATMENT_411,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,4459876,RxNorm,mg/m2,183.0,89.0
SYNTHETIC-1,DONOR_12,TREATMENT_412,Cell-based,Caprelsa,278936,RxNorm,ug/m2,175.0,155.0
SYNTHETIC-1,DONOR_13,TREATMENT_413,,Cobimetinib,987654,RxNorm,g/m2,71.0,162.0
SYNTHETIC-1,DONOR_14,TREATMENT_414,Immune checkpoint inhibitors,Vemurafenib,278936,NCI Thesaurus,g/m2,97.0,124.0
SYNTHETIC-1,DONOR_15,TREATMENT_415,Other immunomodulatory substances,Nivolumab,4459876,NCI Thesaurus,cells/kg,164.0,153.0
SYNTHETIC-1,DONOR_16,TREATMENT_416,Cell-based,Kisqali,239766,NCI Thesaurus,IU/m2,153.0,139.0
SYNTHETIC-1,DONOR_17,TREATMENT_417,Cell-based,Nivolumab,239766,,,76.0,
SYNTHETIC-1,DONOR_18,TREATMENT_418,Other immunomodulatory substances,Pembrolizumab,4459876,,,,82.0
SYNTHETIC-1,DONOR_19,TREATMENT_419,Cell-based,Gilteritinib,987654,RxNorm,IU/m2,127.0,148.0
SYNTHETIC-1,DONOR_20,TREATMENT_420,Monoclonal antibodies other than immune checkpoint inhibitors,Opdivo,4459876,,,57.0,138.0
SYNTHETIC-1,DONOR_21,TREATMENT_421,Immune checkpoint inhibitors,Inotuzumab ozogamicin,8836851,RxNorm,IU/kg,66.0,163.0
SYNTHETIC-1,DONOR_22,TREATMENT_422,Immune checkpoint inhibitors,Alectinib,4459876,,IU/kg,71.0,189.0
SYNTHETIC-1,DONOR_23,TREATMENT_423,Monoclonal antibodies other than immune checkpoint inhibitors,Olaparib,239766,,g/m2,75.0,63.0
SYNTHETIC-1,DONOR_24,TREATMENT_424,Other immunomodulatory substances,Mekinist,,NCI Thesaurus,IU/m2,84.0,50.0
SYNTHETIC-1,DONOR_25,TREATMENT_425,Other immunomodulatory substances,Kymriah,4459876,NCI Thesaurus,mg/kg,191.0,
SYNTHETIC-1,DONOR_26,TREATMENT_426,Immune checkpoint inhibitors,Tafinlar,4459876,NCI Thesaurus,IU/m2,99.0,153.0
SYNTHETIC-1,DONOR_27,TREATMENT_427,Immune checkpoint inhibitors,Trastuzumab,8836851,RxNorm,mg/kg,136.0,
SYNTHETIC-1,DONOR_28,TREATMENT_428,Cell-based,,,,g/m2,69.0,196.0
SYNTHETIC-1,DONOR_29,TREATMENT_429,Monoclonal antibodies other than immune checkpoint inhibitors,Encorafenib,987654,NCI Thesaurus,mg/kg,196.0,158.0
SYNTHETIC-1,DONOR_30,TREATMENT_430,Other immunomodulatory substances,,278936,PubChem,mg/m2,96.0,199.0
SYNTHETIC-1,DONOR_31,TREATMENT_431,Other immunomodulatory substances,Ipilimumab,987654,PubChem,cells/kg,147.0,96.0
SYNTHETIC-1,DONOR_32,TREATMENT_432,Monoclonal antibodies other than immune checkpoint inhibitors,,4459876,PubChem,IU/kg,190.0,66.0
SYNTHETIC-1,DONOR_33,TREATMENT_433,Other immunomodulatory substances,,8756456,NCI Thesaurus,IU/kg,93.0,155.0
SYNTHETIC-1,DONOR_34,TREATMENT_434,Immune checkpoint inhibitors,Zelboraf,8836851,NCI Thesaurus,,,198.0
SYNTHETIC-1,DONOR_35,TREATMENT_435,Cell-based,Cotellic,8756456,PubChem,mg/kg,,155.0
SYNTHETIC-1,DONOR_36,TREATMENT_436,Cell-based,Atezolizumab,8756456,PubChem,,98.0,106.0
SYNTHETIC-1,DONOR_37,TREATMENT_437,Monoclonal antibodies other than immune checkpoint inhibitors,Pembrolizumab,239766,PubChem,,123.0,94.0
SYNTHETIC-1,DONOR_38,TREATMENT_438,Monoclonal antibodies other than immune checkpoint inhibitors,Tisagenlecleucel,4459876,NCI Thesaurus,,87.0,114.0
SYNTHETIC-1,DONOR_39,TREATMENT_439,Other immunomodulatory substances,Ceritinib,8836851,RxNorm,ug/m2,62.0,169.0
SYNTHETIC-1,DONOR_40,TREATMENT_440,Cell-based,Palbociclib,4459876,PubChem,,,192.0
SYNTHETIC-1,DONOR_1,TREATMENT_401,Cell-based,Pembrolizumab,239766,RxNorm,ug/m2,82.0,84.0
SYNTHETIC-1,DONOR_2,TREATMENT_402,Other immunomodulatory substances,,8756456,NCI Thesaurus,mg/m2,144.0,163.0
SYNTHETIC-1,DONOR_3,TREATMENT_403,Cell-based,Brigatinib,278936,NCI Thesaurus,mg/kg,115.0,
SYNTHETIC-1,DONOR_4,TREATMENT_404,Monoclonal antibodies other than immune checkpoint inhibitors,Pertuzumab,4459876,RxNorm,mg/m2,75.0,163.0
SYNTHETIC-1,DONOR_5,TREATMENT_405,,Belantamab,8756456,NCI Thesaurus,cells/kg,107.0,78.0
SYNTHETIC-1,DONOR_6,TREATMENT_406,Immune checkpoint inhibitors,Trastuzumab,,PubChem,mg/m2,141.0,84.0
SYNTHETIC-1,DONOR_7,TREATMENT_407,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,NCI Thesaurus,g/m2,,147.0
SYNTHETIC-1,DONOR_8,TREATMENT_408,Immune checkpoint inhibitors,Inotuzumab ozogamicin,8836851,NCI Thesaurus,mg/m2,111.0,64.0
SYNTHETIC-1,DONOR_9,TREATMENT_409,Immune checkpoint inhibitors,Nivolumab,987654,RxNorm,IU/m2,68.0,154.0
SYNTHETIC-1,DONOR_10,TREATMENT_410,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,4459876,PubChem,IU/m2,60.0,56.0
SYNTHETIC-1,DONOR_11,TREATMENT_411,Other immunomodulatory substances,Ipilimumab,987654,RxNorm,mg/m2,85.0,102.0
SYNTHETIC-1,DONOR_12,TREATMENT_412,Other immunomodulatory substances,Lenvima,278936,RxNorm,ug/m2,166.0,150.0
SYNTHETIC-1,DONOR_13,TREATMENT_413,Cell-based,Tisagenlecleucel,,PubChem,cells/kg,63.0,72.0
SYNTHETIC-1,DONOR_14,TREATMENT_414,,,8756456,PubChem,IU/kg,64.0,102.0
SYNTHETIC-1,DONOR_15,TREATMENT_415,Cell-based,Gefitinib,987654,PubChem,g/m2,109.0,173.0
SYNTHETIC-1,DONOR_16,TREATMENT_416,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,IU/kg,119.0,179.0
SYNTHETIC-1,DONOR_17,TREATMENT_417,Other immunomodulatory substances,Ceritinib,,RxNorm,g/m2,172.0,65.0
SYNTHETIC-1,DONOR_18,TREATMENT_418,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,239766,NCI Thesaurus,IU/kg,109.0,69.0
SYNTHETIC-1,DONOR_19,TREATMENT_419,Other immunomodulatory substances,Nivolumab,4459876,PubChem,mg/m2,52.0,
SYNTHETIC-1,DONOR_20,TREATMENT_420,Immune checkpoint inhibitors,Nivolumab,,RxNorm,,139.0,100.0
SYNTHETIC-1,DONOR_21,TREATMENT_421,Immune checkpoint inhibitors,,4459876,PubChem,ug/m2,,67.0
SYNTHETIC-1,DONOR_22,TREATMENT_422,Monoclonal antibodies other than immune checkpoint inhibitors,Mektovi,8756456,NCI Thesaurus,mg/kg,125.0,164.0
SYNTHETIC-1,DONOR_23,TREATMENT_423,Other immunomodulatory substances,Mektovi,987654,RxNorm,ug/m2,148.0,96.0
SYNTHETIC-1,DONOR_24,TREATMENT_424,Immune checkpoint inhibitors,,8836851,NCI Thesaurus,ug/m2,162.0,95.0
SYNTHETIC-1,DONOR_25,TREATMENT_425,Other immunomodulatory substances,Brigatinib,4459876,PubChem,mg/kg,,60.0
SYNTHETIC-1,DONOR_26,TREATMENT_426,Other immunomodulatory substances,Kadcyla,,NCI Thesaurus,IU/kg,,
SYNTHETIC-1,DONOR_27,TREATMENT_427,Monoclonal antibodies other than immune checkpoint inhibitors,Sorafenib,278936,,g/m2,179.0,169.0
SYNTHETIC-1,DONOR_28,TREATMENT_428,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,987654,RxNorm,,,61.0
SYNTHETIC-1,DONOR_29,TREATMENT_429,Monoclonal antibodies other than immune checkpoint inhibitors,Zelboraf,8756456,NCI Thesaurus,IU/kg,,125.0
SYNTHETIC-1,DONOR_30,TREATMENT_430,Immune checkpoint inhibitors,Imfinzi,,PubChem,IU/kg,57.0,183.0
SYNTHETIC-1,DONOR_31,TREATMENT_431,Immune checkpoint inhibitors,Venclexta,4459876,PubChem,IU/m2,169.0,154.0
SYNTHETIC-1,DONOR_32,TREATMENT_432,,,4459876,NCI Thesaurus,IU/m2,182.0,143.0
SYNTHETIC-1,DONOR_33,TREATMENT_433,Other immunomodulatory substances,Obinutuzumab,,PubChem,cells/kg,66.0,191.0
SYNTHETIC-1,DONOR_34,TREATMENT_434,Monoclonal antibodies other than immune checkpoint inhibitors,Tarceva,4459876,PubChem,g/m2,,
SYNTHETIC-1,DONOR_35,TREATMENT_435,,Lenvatinib,8836851,NCI Thesaurus,,105.0,
SYNTHETIC-1,DONOR_36,TREATMENT_436,Monoclonal antibodies other than immune checkpoint inhibitors,Enhertu,,RxNorm,IU/kg,83.0,190.0
SYNTHETIC-1,DONOR_37,TREATMENT_437,Other immunomodulatory substances,Kisqali,987654,PubChem,cells/kg,,124.0
SYNTHETIC-1,DONOR_38,TREATMENT_438,Immune checkpoint inhibitors,Cometriq,4459876,PubChem,ug/m2,69.0,169.0
SYNTHETIC-1,DONOR_39,TREATMENT_439,Other immunomodulatory substances,Herceptin,8836851,NCI Thesaurus,ug/m2,181.0,145.0
SYNTHETIC-1,DONOR_40,TREATMENT_440,,Gilotrif,987654,RxNorm,cells/kg,83.0,90.0
SYNTHETIC-1,DONOR_1,TREATMENT_401,Monoclonal antibodies other than immune checkpoint inhibitors,Gazyva,278936,PubChem,g/m2,153.0,
SYNTHETIC-1,DONOR_2,TREATMENT_402,Immune checkpoint inhibitors,Ibrance,,PubChem,cells/kg,,
SYNTHETIC-1,DONOR_3,TREATMENT_403,Monoclonal antibodies other than immune checkpoint inhibitors,Cobimetinib,987654,RxNorm,IU/m2,147.0,
SYNTHETIC-1,DONOR_4,TREATMENT_404,Immune checkpoint inhibitors,,239766,RxNorm,IU/m2,113.0,54.0
SYNTHETIC-1,DONOR_5,TREATMENT_405,Other immunomodulatory substances,Cabozantinib,987654,,g/m2,54.0,
SYNTHETIC-1,DONOR_6,TREATMENT_406,Monoclonal antibodies other than immune checkpoint inhibitors,Ipilimumab,278936,PubChem,g/m2,83.0,
SYNTHETIC-1,DONOR_7,TREATMENT_407,Immune checkpoint inhibitors,Nivolumab,8836851,PubChem,IU/kg,75.0,82.0
SYNTHETIC-1,DONOR_8,TREATMENT_408,Monoclonal antibodies other than immune checkpoint inhibitors,Alecensa,,PubChem,cells/kg,,65.0
SYNTHETIC-1,DONOR_9,TREATMENT_409,Other immunomodulatory substances,Venetoclax,987654,RxNorm,ug/m2,193.0,73.0
SYNTHETIC-1,DONOR_10,TREATMENT_410,Other immunomodulatory substances,Gazyva,239766,RxNorm,g/m2,98.0,167.0
SYNTHETIC-1,DONOR_11,TREATMENT_411,Cell-based,Tecentriq,239766,RxNorm,mg/m2,54.0,196.0
SYNTHETIC-1,DONOR_12,TREATMENT_412,Cell-based,Kymriah,,,mg/kg,175.0,64.0
SYNTHETIC-1,DONOR_13,TREATMENT_413,Immune checkpoint inhibitors,,,PubChem,mg/kg,71.0,118.0
SYNTHETIC-1,DONOR_14,TREATMENT_414,Cell-based,Tarceva,239766,PubChem,g/m2,117.0,97.0
SYNTHETIC-1,DONOR_15,TREATMENT_415,Other immunomodulatory substances,Yervoy,8836851,,ug/m2,118.0,118.0
SYNTHETIC-1,DONOR_16,TREATMENT_416,,Ceritinib,239766,RxNorm,IU/kg,145.0,165.0
SYNTHETIC-1,DONOR_17,TREATMENT_417,Cell-based,Opdivo,4459876,,mg/m2,102.0,105.0
SYNTHETIC-1,DONOR_18,TREATMENT_418,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,239766,NCI Thesaurus,mg/kg,199.0,126.0
SYNTHETIC-1,DONOR_19,TREATMENT_419,,Sorafenib,4459876,NCI Thesaurus,mg/kg,154.0,147.0
SYNTHETIC-1,DONOR_20,TREATMENT_420,Monoclonal antibodies other than immune checkpoint inhibitors,Afatinib,8756456,RxNorm,IU/m2,,73.0
SYNTHETIC-1,DONOR_21,TREATMENT_421,Monoclonal antibodies other than immune checkpoint inhibitors,Vandetanib,987654,PubChem,cells/kg,135.0,85.0
SYNTHETIC-1,DONOR_22,TREATMENT_422,,Gazyva,4459876,PubChem,cells/kg,180.0,164.0
SYNTHETIC-1,DONOR_23,TREATMENT_423,Cell-based,,8836851,RxNorm,,112.0,132.0
SYNTHETIC-1,DONOR_24,TREATMENT_424,Other immunomodulatory substances,,278936,,mg/m2,150.0,166.0
SYNTHETIC-1,DONOR_25,TREATMENT_425,Cell-based,Erlotinib,8756456,NCI Thesaurus,cells/kg,52.0,60.0
SYNTHETIC-1,DONOR_26,TREATMENT_426,Cell-based,Gefitinib,8836851,RxNorm,mg/kg,130.0,174.0
SYNTHETIC-1,DONOR_27,TREATMENT_427,Cell-based,Binimetinib,239766,RxNorm,IU/kg,162.0,108.0
SYNTHETIC-1,DONOR_28,TREATMENT_428,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,987654,NCI Thesaurus,mg/m2,67.0,92.0
SYNTHETIC-1,DONOR_29,TREATMENT_429,Immune checkpoint inhibitors,Braftovi,4459876,NCI Thesaurus,ug/m2,186.0,95.0
SYNTHETIC-1,DONOR_30,TREATMENT_430,Immune checkpoint inhibitors,Trametinib,8756456,PubChem,,141.0,96.0
SYNTHETIC-1,DONOR_31,TREATMENT_431,Other immunomodulatory substances,Olaparib,8756456,RxNorm,,85.0,128.0
SYNTHETIC-1,DONOR_32,TREATMENT_432,Cell-based,Ipilimumab,987654,RxNorm,g/m2,81.0,
SYNTHETIC-1,DONOR_33,TREATMENT_433,Other immunomodulatory substances,Keytruda,278936,PubChem,,137.0,136.0
SYNTHETIC-1,DONOR_34,TREATMENT_434,Immune checkpoint inhibitors,Tarceva,4459876,NCI Thesaurus,g/m2,80.0,76.0
SYNTHETIC-1,DONOR_35,TREATMENT_435,Other immunomodulatory substances,Yervoy,278936,RxNorm,ug/m2,197.0,
SYNTHETIC-1,DONOR_36,TREATMENT_436,Other immunomodulatory substances,,8756456,NCI Thesaurus,mg/m2,75.0,138.0
SYNTHETIC-1,DONOR_37,TREATMENT_437,Cell-based,Selumitinib,278936,RxNorm,g/m2,107.0,199.0
SYNTHETIC-1,DONOR_38,TREATMENT_438,Monoclonal antibodies other than immune checkpoint inhibitors,Brentuximab vedotin,8756456,RxNorm,,,55.0
SYNTHETIC-1,DONOR_39,TREATMENT_439,Immune checkpoint inhibitors,Gilteritinib,4459876,PubChem,cells/kg,156.0,160.0
SYNTHETIC-1,DONOR_40,TREATMENT_440,Other immunomodulatory substances,Kisqali,8836851,RxNorm,,122.0,159.0
SYNTHETIC-1,DONOR_1,TREATMENT_441,Other immunomodulatory substances,Rubraca,8756456,,mg/kg,64.0,132.0
SYNTHETIC-1,DONOR_2,TREATMENT_442,Cell-based,Ceritinib,239766,NCI Thesaurus,IU/m2,187.0,133.0
SYNTHETIC-1,DONOR_3,TREATMENT_443,Cell-based,Rucaparib,4459876,,mg/m2,192.0,
SYNTHETIC-1,DONOR_4,TREATMENT_444,Monoclonal antibodies other than immune checkpoint inhibitors,Venclexta,239766,,IU/kg,,127.0
SYNTHETIC-1,DONOR_5,TREATMENT_445,Other immunomodulatory substances,Keytruda,,NCI Thesaurus,mg/m2,143.0,117.0
SYNTHETIC-1,DONOR_6,TREATMENT_446,Cell-based,Tecentriq,4459876,RxNorm,ug/m2,162.0,195.0
SYNTHETIC-1,DONOR_7,TREATMENT_447,,Afatinib,8756456,RxNorm,mg/m2,80.0,102.0
SYNTHETIC-1,DONOR_8,TREATMENT_448,Monoclonal antibodies other than immune checkpoint inhibitors,Keytruda,278936,NCI Thesaurus,IU/kg,89.0,137.0
SYNTHETIC-1,DONOR_9,TREATMENT_449,Other immunomodulatory substances,Fam-trastuzumab deruxtecan-nxki,239766,PubChem,ug/m2,54.0,58.0
SYNTHETIC-1,DONOR_10,TREATMENT_450,Cell-based,Axicabtagene ciloleucel,,,IU/kg,88.0,164.0
SYNTHETIC-1,DONOR_11,TREATMENT_451,Immune checkpoint inhibitors,Abemaciclib,,RxNorm,IU/m2,117.0,60.0
SYNTHETIC-1,DONOR_12,TREATMENT_452,,Zejula,239766,NCI Thesaurus,mg/kg,,161.0
SYNTHETIC-1,DONOR_13,TREATMENT_453,Cell-based,Xalkori,8756456,PubChem,mg/m2,185.0,65.0
SYNTHETIC-1,DONOR_14,TREATMENT_454,Monoclonal antibodies other than immune checkpoint inhibitors,,8836851,NCI Thesaurus,mg/kg,193.0,55.0
SYNTHETIC-1,DONOR_15,TREATMENT_455,Immune checkpoint inhibitors,Opdivo,987654,PubChem,mg/kg,70.0,200.0
SYNTHETIC-1,DONOR_16,TREATMENT_456,Monoclonal antibodies other than immune checkpoint inhibitors,Atezolizumab,239766,,mg/kg,,98.0
SYNTHETIC-1,DONOR_17,TREATMENT_457,Immune checkpoint inhibitors,Kymriah,8836851,RxNorm,IU/m2,68.0,169.0
SYNTHETIC-1,DONOR_18,TREATMENT_458,Other immunomodulatory substances,,239766,PubChem,,192.0,106.0
SYNTHETIC-1,DONOR_19,TREATMENT_459,Monoclonal antibodies other than immune checkpoint inhibitors,Trametinib,4459876,PubChem,ug/m2,56.0,190.0
SYNTHETIC-1,DONOR_20,TREATMENT_460,Monoclonal antibodies other than immune checkpoint inhibitors,Lenvatinib,8756456,RxNorm,cells/kg,183.0,84.0
SYNTHETIC-1,DONOR_21,TREATMENT_461,Other immunomodulatory substances,Axicabtagene ciloleucel,278936,RxNorm,,128.0,196.0
SYNTHETIC-1,DONOR_22,TREATMENT_462,Cell-based,Ribociclib,278936,RxNorm,ug/m2,,96.0
SYNTHETIC-1,DONOR_23,TREATMENT_463,Cell-based,Pembrolizumab,,PubChem,mg/m2,187.0,145.0
SYNTHETIC-1,DONOR_24,TREATMENT_464,Immune checkpoint inhibitors,Ibrance,8756456,RxNorm,IU/m2,180.0,82.0
SYNTHETIC-1,DONOR_25,TREATMENT_465,,Yervoy,8756456,NCI Thesaurus,g/m2,124.0,64.0
SYNTHETIC-1,DONOR_26,TREATMENT_466,Cell-based,Encorafenib,278936,RxNorm,IU/m2,,53.0
SYNTHETIC-1,DONOR_27,TREATMENT_467,Other immunomodulatory substances,Crizotinib,4459876,RxNorm,mg/kg,105.0,174.0
SYNTHETIC-1,DONOR_28,TREATMENT_468,Immune checkpoint inhibitors,,,PubChem,,,191.0
SYNTHETIC-1,DONOR_29,TREATMENT_469,,Imfinzi,,,mg/m2,,146.0
SYNTHETIC-1,DONOR_30,TREATMENT_470,Immune checkpoint inhibitors,Alunbrig,4459876,PubChem,,,80.0
SYNTHETIC-1,DONOR_31,TREATMENT_471,Other immunomodulatory substances,Cobimetinib,,RxNorm,mg/m2,,148.0
SYNTHETIC-1,DONOR_32,TREATMENT_472,Monoclonal antibodies other than immune checkpoint inhibitors,,987654,RxNorm,IU/m2,119.0,53.0
SYNTHETIC-1,DONOR_33,TREATMENT_473,Cell-based,Niraparib,8836851,PubChem,mg/kg,,113.0
SYNTHETIC-1,DONOR_34,TREATMENT_474,Monoclonal antibodies other than immune checkpoint inhibitors,Yervoy,4459876,RxNorm,IU/kg,110.0,
SYNTHETIC-1,DONOR_35,TREATMENT_475,Immune checkpoint inhibitors,Nexavar,4459876,PubChem,ug/m2,195.0,58.0
SYNTHETIC-1,DONOR_36,TREATMENT_476,Other immunomodulatory substances,Gilteritinib,8756456,,ug/m2,161.0,93.0
SYNTHETIC-1,DONOR_37,TREATMENT_477,,,8756456,NCI Thesaurus,IU/m2,93.0,
SYNTHETIC-1,DONOR_38,TREATMENT_478,Cell-based,Alunbrig,4459876,NCI Thesaurus,g/m2,113.0,92.0
SYNTHETIC-1,DONOR_39,TREATMENT_479,Other immunomodulatory substances,Osimertinib,278936,PubChem,,112.0,
SYNTHETIC-1,DONOR_40,TREATMENT_480,Other immunomodulatory substances,Trastuzumab,278936,PubChem,IU/m2,92.0,130.0
SYNTHETIC-2,DONOR_NULL,TREATMENT_2a,Other immunomodulatory substances,,,,,,
SYNTHETIC-2,DONOR_NULL,TREATMENT_2a,,Nivolumab,987654,PubChem,,,
SYNTHETIC-2,DONOR_NULL,TREATMENT_1a,,,,,mg/kg,,
SYNTHETIC-2,DONOR_ALL,TREATMENT_ALL_01,Other immunomodulatory substances,Braftovi,2049112,RxNorm,ug/m2,133.0,100.0
